ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
DAAGAT010000001.1_115 # 107966 # 108157 # -1 # ID=1_115;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.505	DAAGAT010000001.1_115 	107966	108157	-	Strict	525	20.7866	OKP-B-10	100.0	3002443	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGTCGCGTATGGATAACACCGAGCTGCCTCACCCTAAGGAAATAGACAATGAAACGCTTCTCCCTGCCGCTGAACGGCGCGTCAACAGTCAGGCGCTATTAGGTCCGGACGGCAAAGTCATTATCGATCACAACGGTCAGGAGTATCTGTTGCGCAAAACTCAGGCCGGTAAACTACTGTTAACCAAATAA	MSRMDNTELPHPKEIDNETLLPAAERRVNSQALLGPDGKVIIDHNGQEYLLRKTQAGKLLLTK	MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPANMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMAERNQQIAVIGAALIEHWQR	22.03	gnl|BL_ORD_ID|411|hsp_num:0	443	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000001.1_249 # 246884 # 247246 # 1 # ID=1_249;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.446	DAAGAT010000001.1_249	246884	247246	+	Strict	150	177.178	Klebsiella pneumoniae KpnE	76.67	3004580	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; lincosamide antibiotic; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTTTACTGGATTTTATTAGCTCTGGCTATCGCGACTGAAATTACCGGCACGCTCTCAATGAAATGGGCTAGCGTGGGTAATGGCAATGCGGGTTTTATTTTAATGCTGGTGATGATCACGCTGTCATATATATTTCTTTCTTTTGCGGTAAAAAAGATTGCCCTGGGTGTAGCGTATGCCTTATGGGAAGGGATCGGCATTTTATTTATTACCATTTTTAGCGTGCTGCTATTTGATGAAGCATTATCAACCATGAAGATTGCCGGCTTGCTGACGCTGGTCGCCGGCATAGTATTGATCAAATCAGGGACGCGTAAACCCGGCAAACCGGTGAAGGAGGCGACTCGTGCAACAATTTGA	MFYWILLALAIATEITGTLSMKWASVGNGNAGFILMLVMITLSYIFLSFAVKKIALGVAYALWEGIGILFITIFSVLLFDEALSTMKIAGLLTLVAGIVLIKSGTRKPGKPVKEATRATI	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV	100.00	gnl|BL_ORD_ID|2747|hsp_num:0	3283		
DAAGAT010000001.1_250 # 247233 # 247562 # 1 # ID=1_250;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.555	DAAGAT010000001.1_250	247233	247562	+	Strict	150	185.267	Klebsiella pneumoniae KpnF	87.16	3004583	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; lincosamide antibiotic; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCAACAATTTGAATGGATACACGGCGCCTGGCTTGGGCTGGCAATAATGCTGGAAATCGCGGCTAACGTACTGTTGAAATTTTCGGACGGCTTTCGTCGTAAATGCTATGGCATCTTATCGCTTGCCGCTGTTCTGGCCGCCTTCAGCGCGCTTTCCCAGGCGGTAAAAGGGATAGACCTGTCGGTGGCGTATGCGTTATGGGGCGGTTTTGGTATTGCCGCCACGCTGGCGGCGGGCTGGGTGCTCTTCGGCCAGCGCTTAAACCCCAAAGGCTGGGTTGGCGTGATATTGCTGCTCGCCGGAATGGTCATGATCAAATTTGCCTGA	MQQFEWIHGAWLGLAIMLEIAANVLLKFSDGFRRKCYGILSLAAVLAAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWVLFGQRLNPKGWVGVILLLAGMVMIKFA	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	100.00	gnl|BL_ORD_ID|2750|hsp_num:0	3286		
DAAGAT010000001.1_287 # 283729 # 284112 # -1 # ID=1_287;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.471	DAAGAT010000001.1_287	283729	284112	-	Strict	230	251.136	marA	95.24	3000263	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; penem; antibacterial free fatty acids	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGTCCAGACGCAACACTGACGCTATTACTATTCATAGCATTTTGGACTGGATCGAGGATAACCTGGAGTCGCCGCTCTCACTGGAAAAAGTGTCTGAGCGTTCAGGATATTCCAAATGGCACCTGCAACGGATGTTTAAAAAAGAGACCGGTCATTCATTAGGTCAATACATCCGCAGCCGTAAGATGACGGAAATCGCGCAAAAATTAAAAGAGAGCAACGAGCCCATTCTCTATCTGGCGGAACGCTATGGCTTTGAGTCACAGCAAACATTGACCCGGACGTTCAAAAACTACTTTGATGTGCCGCCACACAAATACCGGATCACCAATATGCATGGCGAATCACGGTATATGCTGCCGCTGAACCATGGCAACTACTAG	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNMHGESRYMLPLNHGNY	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS	100.00	gnl|BL_ORD_ID|1818|hsp_num:0	1922		
DAAGAT010000001.1_391 # 395515 # 395952 # 1 # ID=1_391;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.523	DAAGAT010000001.1_391	395515	395952	+	Strict	275	301.212	AAC(6')-Iy	97.93	3002569	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGACATCAGGCAAATGAACAAAACCAATCTGGAGCACTGGCGCGGATTGCGAAAACAGCTCTGGCCCGGTCACCCGGATGACGCCCATCTGGCAGACGGCGAAGAAATCCTGCAAGCCGATCATCTGGCATCATTTATTGCGATGGCAGACGGGGTGGCGATTGGCTTTGCGGATGCCTCAATCCGCCACGATTATGTTAATGGCTGTGACAGTTCGCCCGTGGCTTTCCTTGAAGGTATTTTTGTTCTCCCCTCGTTCCGTCAACGCGGCGTAGCGAAACAATTGATTGCAGCGGTGCAACGATGGGGAACGAATAAAGGGTGTCGGGAAATGGCCTCCGATACCACGCCGGAAAATACAATTTCCCAGAAAGTTCACCAGGCGTTAGGATTTGAGGAAACAGAGCGCGTCATTTTCTACCGAAAGCGTTGTTGA	MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADASIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPENTISQKVHQALGFEETERVIFYRKRC	MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADASIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQALGFEETERVIFYRKRC	100.00	gnl|BL_ORD_ID|335|hsp_num:0	360		
DAAGAT010000002.1_314 # 351409 # 352650 # 1 # ID=2_314;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.576	DAAGAT010000002.1_314	351409	352650	+	Strict	700	708.753	mdtM	86.03	3001214	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAACGGATTATTCAGTTTTTCTCCCAACGCGCCACAACGTTATTTTTCCCGATGGCGCTGATTTTGTACGATTTTGCCGCCTATCTGACGACGGATCTGATTCAGCCTGGCATCATTAACGTCGTGCGCGATTTTAATGCTGACGTCAGTCTTGCGCCGGCCTCGGTCAGTCTCTATCTGGCGGGCGGAATGGCGTTGCAATGGCTTCTGGGGCCGCTATCCGACAGGATTGGCCGCCGGCCAGTGCTGATTGCAGGGGCATTAATTTTTACTCTCGCCTGCGCGGCAACGCTGTTGACGACCTCAATGACGCAGTTTCTGGTTGCCCGTTTTGTGCAGGGCACCAGCATTTGCTTTATCGCAACGGTCGGCTACGTCACGGTACAGGAGGCCTTCGGTCAAACCAAAGCCATTAAGCTGATGGCGATTATTACCTCCATTGTGCTGGTCGCTCCGGTTATCGGCCCGCTCTCCGGCGCCGCGCTGATGCACTTCGTTCACTGGAAGGTGCTGTTCGGTATTATTGCGGTGATGGGACTGTTGGCGTTGTGCGGCCTGCTGCTGGCGATGCCGGAAACGGTGCAACGCGGCGCGGTGCCGTTCAGCGCGGTGAGCGTACTGCGCGATTTTCGTAATGTGTTTCGCAACCCGATTTTTCTCACCGGGGCGGCGACGCTGTCGTTGAGCTACATCCCGATGATGAGCTGGGTGGCGGTGTCGCCGGTGATCCTGATCGATGCCGGCGGGATGAGTACTTCGCAATTCGCCTGGGCGCAGGTGCCCGTATTCGGCGCGGTGATCGTGGCCAATATGATCGTTGTGCGCCTGGTGAAAGATCCGACCCGACCGCGTTTTATCTGGCGCGCCGTACCAATTCAGTTAAGCGGGCTGGCGACATTGCTCCTCGGTAATCTTCTTCTGCCGCACGTCTGGCTTTGGTCTGTGCTGGGCACCAGCCTGTACGCGTTCGGCATTGGAATGATTTTCCCGACGCTGTTTCGCTTCACGCTTTTCTCCAACAACTTGCCAAAAGGGACGGTTTCAGCCTCGCTGAACATGGTGATTCTGACGGTGATGGCGGTGTCGGTCGAAGTTGGCCGCTGGCTGTGGTTTCACGGCGGGAGACTGCCGTTTCACCTGCTGGCAGCGGTGGCCGGGGTGATTGTGGTCTTCACCCTGGCGACATTATTACAGCGCGTGCGCCAGCATGAGGCGGCAGAACTGGCCGCTGAGAAGTAA	MQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLYLAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICFIATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMGLLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAVSPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLATLLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVMAVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELAAEK	MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIATVGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFISFVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPVILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIVGNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ	100.73	gnl|BL_ORD_ID|1124|hsp_num:0	1191		
DAAGAT010000003.1_50 # 46881 # 47603 # -1 # ID=3_50;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.492	DAAGAT010000003.1_50	46881	47603	-	Strict	470	504.212	sdiA	99.58	3000826	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAGGAAAATGATTTCTTCACCTGGCGACGCGCAATGTTGTTACGCTTTCAGGAGATGGCGGCAGCAGAGGATGTTTATACTGAATTGCAATATCAGACACAGCGGCTGGAATTTGATTATTATGCCCTGTGTGTTCGTCATCCCGTCCCCTTTACCCGGCCTAAAATATCGCTTCGTACCACTTATCCTCCGGCGTGGGTAACGCATTACCAGTCCGAAAACTATTTTGCGATCGATCCGGTATTAAAGCCGGAAAATTTCAGGCAGGGTCATTTACATTGGGATGACGTGCTATTTCATGAAGCGCAGGCGATGTGGGATGCCGCCCAGCGTTTCGGATTACGCAGAGGCGTAACCCAGTGTGTGATGTTGCCGAACCGGGCGCTGGGCTTTTTATCTTTCTCTCGTAGCAGTTTACGCTGCTCCTCGTTTACCTACGATGAAGTGGAGCTGAGGTTGCAACTGCTGGCGCGGGAGAGTCTTTCGGCGCTGACAAGATTTGAAGACGACATGGTGATGGCGCCTGAGATGCGTTTCAGTAAACGTGAGAAAGAGATTCTGAAGTGGACGGCGGAAGGGAAGACCTCATCGGAGATCGCCATTATTCTGTCGATTTCTGAAAATACCGTTAACTTCCATCAGAAAAACATGCAGAAGAAATTCAATGCGCCCAATAAAACACAGATTGCCTGCTACGCTGCGGCGACAGGTCTGATATGA	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAQAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	100.00	gnl|BL_ORD_ID|212|hsp_num:0	228		
DAAGAT010000003.1_108 # 100009 # 101433 # -1 # ID=3_108;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.540	DAAGAT010000003.1_108	100009	101433	-	Strict	900	930.243	MdtK	99.58	3001327	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; acridine dye	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	TTGAACGTCTCCACTGCCTTACGCCAGGCTGTCGTCCGTACGCCCTGGTATGCCAAACGCAAGAGCTACAAAGTGTTGTTCTGGCGTGAAATCACCCCACTTGCTATCCCTATTTTTCTGGAAAATACCTGTGTTTTGCTAATGGGCGTGCTCAGTACTTTTCTCGTCAGTTGGCTGGGCAAGGAAGCAATGGCGGGCGTGGGGCTTGCCGACAGTTTTAATATGGTAATTATGGCTTTTTTTGCGGCTATCGATCTTGGTACTACGGTGGTGGTTGCCTTTAGCCTGGGCAAGCGCGACAGGCGACGGGCAAGGGCGGCGGCGCGCCAGTCGCTGGTGATTATGACGCTATTTGCCGTTGTGCTGGCAGTGGTCATTCATTATTTCGGCAGTGAAATTATTAATATTGTCGCAGGCGAGGCGACGCCAGAAGTAAAGGGGCTGGCGTTAACGTACCTTGAACTGACGGTGCTGAGTTATCCGGCTGCGGCAATTGCGCTAATCGGTAGCGGCGCGCTGCGTGGGGCAGGGAATACTAAAATCCCGTTGATGATTAACGGCGGGATGAACATTCTCAATATTATCATCAGCAGCATCCTGATTTACGGGGCTTTCTCCTGGCAAGGGCTGGGTTTTGCCGGCGCGGGGCTGGGATTAACCATTTCGCGCTACATCGGCGCGGTAGCGATTATTTGGGTGCTGATGATTGGTTTTAATCCGGCGCTGCGCATTCCGCTGAAAAGCTATCTGAAGCCGCTGAATTTCGGCATTATCTGGGAAGTGATGGGGATTGGTATTCCGGCGAGCATTGAATCAGTGCTGTTCAACGGTGGCAAACTACTGACGCAAATGTTTGTCGCCGGAATGGGCACTAACGTTATTGCGGGTAACTTTATTGCCTTTTCCGTGGCGGCGCTTATCAACCTGCCGGGTAACGCCCTTGGTTCGGCGTCGACTATTATCACCGGTAAGCGTCTTGGTACCGGGCAAATTGGTCAGGCAGAGCGTCAACTGCGCCATGTATTCTGGATGTCGACTATCGTACTTACGGCAATTGCCTGGGGGACGGCGCCGTTCGCGGGTCTGTTTGCCTCATTTTATACCCAGGAGCAGGACGTAAAAGAGGTAGTGAAAGTTCTGCTCTGGCTTAATGCTGCCTTTATGCCAATTTGGGCGGCCGCGTGGGTGCTGCCGTCGGGTTTTAAAGGCGCGCGCGATGTGCGATTTGCGATGTGGGTATCGATGCTGGGGATGTGGGGCTGTCGCGTTGTGGCAGGGTATACGCTTGGTATTGTGCTGGGTATGGGGGTTGTAGGGGTTTGGCTGGGGATGTTTCTTGACTGGGCCGTGCGCGGCGCGCTGTTTTACTGGCGTCTGGTAAGCGGGCGCTGGCTGTGGAGATACCCGCGCGTAAAGAGGGAGTAA	MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVVLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTKIPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNPALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGGKLLTQMFVAGMGTNVIAGNFIAFSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFAGLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWGCRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLVSGRWLWRYPRVKRE	MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVVLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTKIPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNPALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGSKLLTQMFVAGMGTNVIAGNFIAFSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFAGLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWGCRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLISGRWLWRYPRVKRE	100.00	gnl|BL_ORD_ID|1654|hsp_num:0	1752		
DAAGAT010000003.1_144 # 131041 # 132051 # 1 # ID=3_144;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.609	DAAGAT010000003.1_144 	131041	132051	+	Strict	900	24.6386	basS	100.0	3003583	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGCGATTTATACCCGAACAGGTGACGCTGGCACCACATCACTGTTTACCGGCCAGCGGGTGAGCAAAACCCACCCGCGGGTTGAAGCCTACGGCACGCTGGATGAGCTGAACGCCGCGCTGAGCCTGTGCGCCTGCGCCGCTGCGGATGAAAATCACCGCACCTTACTCGAGGCCATCCAGCAGCAACTTTTTTGGTTTAGCGCAGAGCTGGCCAGCGACAGCGAGCAGCCGTCGCCCAAACAGCGCTACATCAGCAGCGAAGAGATTTCGGCTCTGGAAGCCGCTATCGATCGGGCAATGGCCCGCGTCGAACCGCTGCACAGCTTTATTTTACCCGGACGCTGCGAAGCCGCGAGCCGCTTACATTTTGCCCGCACGCTGGCGCGCCGCGCCGAACGCCGTCTGGTTGAACTGGCAACTGAAGTCAACGTACGCCAGGTGCTGATGCGCTACATCAACCGCTTATCGGACTGCCTGTACGCCCTGGCCCGCGCGGAAGATAGCGATGCGCACCAGGCCAACATCATCCGTGAAGTTAGCAAGCGCTATCTGGCTGCCAGCCAGCCGACCCGCAGCAAGGAGACAACGCCCGTGGCCCTCTCATTCCACGATCTGCACCAGCTCACCCGCGCCGCCGTTGAACGCGCGCAGCAACTGCAGGTTCCGGTAGTCGTCAGCATCGTTGACGCGCACGGCACGGAAACTGTGACCTGGCGGATGCCGGACGCCCTGCTGGTCAGCAGCGAACTGGCGCCGAAAAAGGCATGGACCGCAGTGGCAATGAAAACGGCGACCCATGAGCTGAGCGATGTTGTTCAGCCAGGCGCGGCGCTTTATGGCCTGGAAAGTCATTTACAGGGAAAAGTGGTCACCTTTGGCGGCGGTTACGCCCTGTGGCGCGACGGCATATTAATTGGGGGTCTTGGCATCAGCGGCGGCAGCGTTGAGCAGGACATGGACATAGCACAGACCGCCATCGCGGCTATTAACGTGGGAACTCATCAATGA	MAIYTRTGDAGTTSLFTGQRVSKTHPRVEAYGTLDELNAALSLCACAAADENHRTLLEAIQQQLFWFSAELASDSEQPSPKQRYISSEEISALEAAIDRAMARVEPLHSFILPGRCEAASRLHFARTLARRAERRLVELATEVNVRQVLMRYINRLSDCLYALARAEDSDAHQANIIREVSKRYLAASQPTRSKETTPVALSFHDLHQLTRAAVERAQQLQVPVVVSIVDAHGTETVTWRMPDALLVSSELAPKKAWTAVAMKTATHELSDVVQPGAALYGLESHLQGKVVTFGGGYALWRDGILIGGLGISGGSVEQDMDIAQTAIAAINVGTHQ	MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI	70.44	gnl|BL_ORD_ID|2421|hsp_num:0	249	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000003.1_174 # 163783 # 164949 # -1 # ID=3_174;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.440	DAAGAT010000003.1_174	163783	164949	-	Strict	700	716.072	ugd	89.18	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAATCACGATATCCGGGACGGGTTATGTTGGCTTGTCTAATGGTTTGCTTATTGCACAACATCATGATGTGGTGGCGTTAGACATTGTTCCTTCCCGTGTTGAACTGTTAAATGATCGGATATCTCCGATTGTTGATAAAGAAATTCAGCAATTTTTAAAGGAAGATAACATCAGATTCAGGGCAACGCTGGATAAGTTTGATGCGTACCAGAATGCAGATTACGTCATCATTGCTACGCCTACGGATTACGATCCCAAAACCAACTATTTTAATACGTCCAGTGTGGAATCGGTCATTCAGGATGTGATCAGCATCAACCCCGCAGCCGTGATGATTATTAAGTCTACGGTGCCGGTTGGCTTCACGGCGGCAATGCGTCAGAAGTTTGCGACAGAAAATATCATTTTCTCTCCGGAGTTTTTACGTGAAGGTAAAGCCCTTTACGATAACCTTTATCCCTCCCGTATCGTGATTGGGGAACAGTCTGAGCGCGCCAGAGAATTTGCCGCATTACTCCAGGAAGGCGCTATTAAACAGGAGATTCCAACGCTGTTTACGGACTCCACTGAGGCGGAAGCTATTAAACTTTTCGCCAATACTTATCTCGCTATGCGAGTCGCTTATTTTAATGAATTAGACAGCTATGCTGAAACGTTAGGATTAAATACCCGACAAATTATTGAAGGGGTGTGCCTCGACCCGCGTATTGGCAATCATTATAATAATCCCTCTTTTGGTTATGGCGGATATTGTTTGCCAAAAGATACCAAACAGTTGCTGGCCAATTATCAGTCGGTGCCTAATAATATTATCTCCGCTATCGTTGAAGCAAACCGTACGCGTAAAGATTTTATTGCCGACGCTATCCTCGCCAGAAAGCCTAAAGTGGTGGGCATTTATCGCCTGATTATGAAGAGTGGCTCCGATAACTTCCGCGCCTCATCGATTCAGGGGATTATGAAGCGCATTAAAGCGAAAGGCGTAGAGGTCATCATCTATGAGCCGGTAATGGAAGAAGATACTTTCTTTAACTCACGTCTTGAACGTGATTTGCACTGCTTTAAACAGCAGGCGGATGTCATTATTTCCAACAGGATGGCGGCAGAGCTTTTGGATGTCGCTGAAAAAGTGTATACCCGCGATCTTTTCGGTAGTGATTAA	MKITISGTGYVGLSNGLLIAQHHDVVALDIVPSRVELLNDRISPIVDKEIQQFLKEDNIRFRATLDKFDAYQNADYVIIATPTDYDPKTNYFNTSSVESVIQDVISINPAAVMIIKSTVPVGFTAAMRQKFATENIIFSPEFLREGKALYDNLYPSRIVIGEQSERAREFAALLQEGAIKQEIPTLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAETLGLNTRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNIISAIVEANRTRKDFIADAILARKPKVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMEEDTFFNSRLERDLHCFKQQADVIISNRMAAELLDVAEKVYTRDLFGSD	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	100.00	gnl|BL_ORD_ID|916|hsp_num:0	842		
DAAGAT010000003.1_212 # 212522 # 215644 # 1 # ID=3_212;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.582	DAAGAT010000003.1_212	212522	215644	+	Strict	1800	1866.66	mdtB	91.73	3000793	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAGGTATTACCTCCGGGCAGCACGGGCGGCCCCTCGCGTCTGTTTATTCTGCGCCCCGTGGCCACCACTCTGCTGATGGCGGCGATTTTACTCGCCGGGATTATCGGCTATCGCTTCCTGCCCGTCGCCGCTTTGCCGGAGGTCGACTACCCCACTATTCAGGTTGTTACGCTCTACCCTGGCGCCAGCCCGGATGTCATGACCTCCGCCGTCACCGCGCCGCTTGAGCGCCAGTTCGGCCAGATGTCAGGACTGAAGCAGATGTCGTCGCAAAGTTCCGGCGGCGCATCGGTGGTGACGCTACAGTTTCAGTTGACGCTGCCGCTGGACGTTGCCGAGCAGGAAGTACAGGCGGCGATTAACGCAGCCACCAATTTATTGCCTTCCGACCTGCCGAATCCGCCGATTTTTAGCAAAGTCAATCCGGCGGACCCGCCGATTATGACGCTTGCCGTCACCTCAAACGCGATGCCAATGACTCAGGTAGAGGACATGGTAGAAACCCGCGTGGCGCAGAAGATCTCGCAGGTCTCCGGCGTCGGACTGGTGACGCTTGCCGGCGGGCAGCGCCCTGCGGTGCGTGTAAAACTGAATGCTCAGGCTATCGCCGCGCTCGGTCTGACCAGCGAAACGGTCCGTACCGCAATTACCGGCGCCAACGTCAACTCGGCGAAAGGCAGTCTGGATGGCCCCGAACGGGCGGTGACGCTTTCTGCTAACGATCAGATGCAGTCTGCCGACGAATACCGCAGGCTTATCATCGCGTATCAAAACGGTGCGCCGGTACGGTTGGGCGATGTCGCCACCGTCGAACAGGGGGCGGAAAATAGCTGGCTCGGCGCATGGGCGAATCAAGCGCCGGCTATCGTGATGAACGTTCAACGCCAGCCCGGCGTCAATATCATTGCGACAGCGGACAGCATTCGCCAGATGCTGCCCCAGCTTACCGAAAGCCTGCCAAAATCGGTGAAGGTCACGGTCCTGTCCGATCGCACCACCAATATTCGCGCTTCCGTGCGCGATACCCAGTTTGAACTGATGCTGGCGATCGCGCTGGTCGTCATGATTATCTATCTGTTTTTACGTAATATTCCCGCCACAATTATTCCCGGCGTCGCCGTACCGCTGTCGCTTATCGGCACCTTTGCGGTGATGGTGTTTTTGGATTTTTCCATTAATAACCTGACGCTGATGGCGCTCACTATCGCCACGGGTTTCGTGGTGGACGATGCGATTGTGGTGATCGAGAACATCTCGCGCTACATCGAAAAAGGAGAAAAACCGCTGGCGGCGGCGCTCAAAGGCGCGGGCGAAATCGGCTTTACCATTATTTCCCTCACCTTTTCACTGATTGCGGTGCTGATCCCGTTGCTCTTTATGGGCGATATTGTTGGTCGACTGTTCCGCGAATTTGCGGTGACGTTGGCGGTAGCGATTTTAATCTCCGCCGTCGTCTCTTTGACGCTCACGCCCATGATGTGCGCGCGTATGCTCAGCCAGCAGTCTCTGCGTAAACAAAACCGCTTTTCCTGCGCCTGCGAGCGGATGTTTGACCGCGTGATCGCCAGCTACGGACGTGGATTAGCGAAAGTGCTCAACCATCCGTGGCTTACATTGAGCGTGGCATTCGCCACGCTCCTGCTCAGCGTTATGCTGTGGATAGTCATTCCGAAAGGGTTCTTTCCGGTACAGGATAACGGCATTATCCAGGGGACGCTGCAGGCGCCGCAATCGTCATCGTATGCCAGTATGGCGCAACGTCAGCGCCAGGTGGCGGAGCGGATATTACAGGACCCGGCGGTGCAAAGCCTGACGACTTTTGTTGGCGTAGACGGCGCTAATCCCACGCTGAATAGCGCGCGCCTGCAAATTAACCTCAAGCCGCTGGATGCGCGTGATGACCGCGTGCAGCAGGTGATCTCCCGGCTGCAAACCGCCGTGGCGACGATTCCCGGCGTGGTGCTGTATCTCCAGCCGACGCAGGATTTAACCATCGACACGCAGGTCAGCCGCACGCAGTATCAGTTTACCCTGCAGGCCACGACGCTCGATGCGCTCAGCCACTGGGTGCCAAAACTGCAGAACGCGCTACAGTCGTTACCACAGCTTTCCGAGGTAAGCAGCGACTGGCAAGATCGAGGATTAGCGGCCTGGGTGAATGTCGACCGCGACAGCGCCAGCCGTCTGGGTATCAGCATGGCGGATGTGGATAACGCGCTCTACAACGCGTTCGGACAACGCCTGATTTCAACGATTTATACCCAGGCGAACCAGTACCGCGTCGTGCTGGAACATAATACCGCCAGCACGCCGGGCCTGGCGGCGCTGGAGACGATTCGCCTGACGAGCCGCGACGGCGGCACCGTACCGCTCAGCGCGATTGCCCGCATTGAGCAGCGCTTCGCTCCGCTCTCCATCAATCATTTAGATCAGTTCCCGGTTACGACATTTTCGTTTAACGTGCCGGAGGGCTATTCGCTCGGCGATGCGGTGCAGGCGATTCTCGATACGGAAAAAACGCTCGCCCTGCCAGCGGATATTACAACGCAGTTTCAGGGCAGTACGCTCGCCTTCCAGGCGGCGCTGGGCAGCACCGTCTGGCTTATTGTCGCCGCCGTGGTGGCGATGTATATCGTGCTCGGCGTGCTGTATGAGAGTTTTATCCATCCGATCACGATTCTCTCAACGCTGCCTACGGCGGGCGTCGGCGCGCTACTGGCGCTGATCATCGCTGGTAGCGAGCTCGATATTATCGCCATTATCGGCATTATTTTGCTGATCGGCATCGTGAAGAAAAACGCCATCATGATGATTGACTTCGCCCTCGCCGCTGAACGCGAACAGGGGATGAGTCCGCGCGACGCTATCTTCCAGGCCTGTCTGCTGCGTTTTCGACCGATTCTGATGACCACGCTGGCGGCGTTGCTCGGGGCATTGCCATTAATGTTGAGTACCGGCGTTGGCGCGGAATTACGTCGCCCGTTGGGGATCGCGATGGTGGGCGGCCTACTGGTCAGCCAGGTATTAACTCTGTTTACCACACCGGTGATTTATCTCCTGTTTGACCGCCTGTCGCTGTACGTGAAAAGTCGCTTTCCGCGCCATAAAGAGGAGGCGTAG	MQVLPPGSTGGPSRLFILRPVATTLLMAAILLAGIIGYRFLPVAALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPIFSKVNPADPPIMTLAVTSNAMPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPERAVTLSANDQMQSADEYRRLIIAYQNGAPVRLGDVATVEQGAENSWLGAWANQAPAIVMNVQRQPGVNIIATADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSQQSLRKQNRFSCACERMFDRVIASYGRGLAKVLNHPWLTLSVAFATLLLSVMLWIVIPKGFFPVQDNGIIQGTLQAPQSSSYASMAQRQRQVAERILQDPAVQSLTTFVGVDGANPTLNSARLQINLKPLDARDDRVQQVISRLQTAVATIPGVVLYLQPTQDLTIDTQVSRTQYQFTLQATTLDALSHWVPKLQNALQSLPQLSEVSSDWQDRGLAAWVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTASTPGLAALETIRLTSRDGGTVPLSAIARIEQRFAPLSINHLDQFPVTTFSFNVPEGYSLGDAVQAILDTEKTLALPADITTQFQGSTLAFQAALGSTVWLIVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALIIAGSELDIIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPRDAIFQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIAMVGGLLVSQVLTLFTTPVIYLLFDRLSLYVKSRFPRHKEEA	MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA	100.00	gnl|BL_ORD_ID|776|hsp_num:0	820		
DAAGAT010000003.1_213 # 215645 # 218725 # 1 # ID=3_213;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.568	DAAGAT010000003.1_213	215645	218725	+	Strict	1800	1857.8	mdtC	91.51	3000794	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCTTTTTCGCCCTTTTCATCTACCGCCCGGTCGCCACCATTTTGATTGCCGCCGCCATTACGCTGTGCGGCATTCTGGGCTTTCGTCTGCTGCCGGTCGCCCCGCTGCCGCAGGTTGATTTCCCGGTGATTATGGTTAGCGCCTCGCTACCGGGTGCCTCGCCGGAAACCATGGCTTCGTCGGTGGCGACGCCGTTGGAACGCTCTTTAGGACGCATTGCAGGCGTCAATGAAATGACCTCCAGCAGCTCGCTCGGCAGCACGCGCATTATTCTCGAATTTAATTTCGATCGTGATATTAACGGCGCGGCGCGCGACGTGCAGGCCGCCATTAACGCCGCGCAAAGCTTGTTGCCAGGCGGAATGCCCAGCCGCCCGACTTATCGCAAGGCCAACCCGTCCGACGCGCCGATTATGATTTTAACGCTCACCTCGGAGAGCTGGTCACAGGGCAAACTGTATGATTTCGCCTCTACCCAACTGGCGCAAACCATCGCGCAAATTGACGGCGTCGGCGACGTTGACGTCGGCGGCAGCTCCCTGCCCGCAGTACGTGTAGGCTTAAACCCGCAGGCGCTCTTTAACCAGGGCGTCTCGCTGGATGAGGTCCGCGAAGCGATCGACAGCGCCAACGTACGCCGACCGCAAGGCGCAATTGAAGATAGCGTCCACCGCTGGCAAATCCAGACCAACGACGAACTGAAAACCGCCGCCGAATACCAGCCGCTGATTATTCACTATAACAACGGCGCGGCGGTACGCCTGGGCGACGTCGCCAGCGTCACCGACTCGGTGCAGGATGTCCGTAACGCCGGGATGACGAACGCTAAACCCGCTATTTTGTTGATGATCCGCAAGCTGCCGGAGGCCAACATTATTCAGACGGTCGACGGCATCCGGGCAAAACTGCCGGAACTGCGGGCAATGATCCCCGCCGCTATCGATTTACAAATCGTCCAGGATCGTTCGCCGACGATTCGCGCGTCGCTGCAAGAGGTAGAAGAGACGCTGGCTATCTCTGTCGCGCTGGTGATCCTGGTGGTGTTTTTATTCCTGCGTTCCGGGCGCGCCACGCTAATCCCCGCCGTCGCCGTTCCCGTTTCGCTCATCGGCACCTTCGCCGCCATGTATCTGTGCGGCTTCAGCCTCAACAATCTGTCGCTGATGGCGCTGACTATCGCGACCGGATTTGTCGTTGATGATGCCATTGTGGTGCTGGAAAATATCGCCCGCCATCTGGAGGCGGGAATGAAACCTTTGCAGGCGGCATTACAGGGTACGCGGGAAGTCGGGTTTACGGTCATCTCCATGAGTCTGTCGCTGGTGGCGGTATTTCTGCCGCTGCTGTTAATGGGCGGTCTGCCAGGGCGATTATTACGGGAATTCGCCGTTACCCTCTCGGTGGCGATTGGCATTTCGCTGGTGGTCTCACTCACGCTGACGCCGATGATGTGCGGCTGGATGCTTAAATCAAGCAAACCGCGCACCCAACCGCGTAAACGGGGCGTTGGCCGTTTGCTGGTAGCTTTGCAACAGGGTTACGGCACGTCGTTAAAATGGGTGCTTAACCATACGCGTCTTGTCGGTGTGGTTTTTCTTGGCACCGTTGCGCTGAACATCTGGCTTTATATCGCCATCCCTAAAACATTCTTTCCGGAGCAGGACACCGGCGTGTTGATGGGCGGTATTCAGGCTGACCAGAGCATCTCTTTCCAGGCCATGCGCGGCAAGCTGCAGGATTTTATGAAAATTATTCGCGACGATCCGGCGGTGAATAATGTCACTGGTTTTACCGGCGGCTCGCGGGTGAATAGCGGCATGATGTTTATTACGCTGAAGCCGCGCGGCGAACGCAAAGAGACGGCGCAGCAAATCATTGATCGACTGCGGGTCAAACTGGCAAAAGAACCCGGCGCCAGGCTGTTTCTGATGGCGGTACAGGATATTCGCGTCGGCGGGCGGCAGGCTAACGCCAGTTATCAATACACATTGCTGTCTGACTCCCTGGCGGCGCTGCGCGAGTGGGAGCCGAAAATACGCAAAGCGCTCTCGGCCCTGCCGCAACTGGCGGACGTAAACTCCGACCAGCAGGATAACGGCGCGGAGATGAACCTTATCTACGACCGCGACACCATGTCACGACTGGGCATTGATGTTCAGGCCGCAAACAGTCTGTTAAATAATGCTTTCGGCCAGCGGCAAATTTCCACCATTTATCAGCCGATGAACCAGTATAAAGTGGTGATGGAAGTCGATCCGCGCTATAGCCAGGATATCAGCGCGCTGGAGAAAATGTTTGTTATCAACCGTGACGGAAAAGCGATCCCCCTCTCTTATTTCGCCCAATGGCGGCCCGCCAATGCGCCGCTGTCGGTGAACCATCAGGGACTTTCCGCGGCGTCCACGATTGCCTTTAACCTGCCGACCGGCACATCGTTATCGCAGGCGACGGAGGCCATTAATCGCACCATGACGCAGCTTGGCGTCCCTCCGACGGTACGCGGCAGTTTTTCCGGAACGGCGCAAGTGTTCCAGCAGACCATGAATTCGCAGCTTATTTTGATAGTGGCGGCGATCGCTACCGTCTACATTGTGCTGGGGATACTGTACGAAAGTTACGTCCATCCGCTGACCATTCTCTCTACTCTGCCATCGGCGGGCGTTGGGGCGCTTCTGGCGCTGGAACTCTTCAATGCCCCTTTCAGCCTAATCGCCCTGATAGGGATCATGCTATTAATTGGCATTGTGAAGAAAAACGCCATTATGATGGTCGATTTTGCGCTTGAAGCGCAACGAAGCGGCGGCCTGACGCCGGAACAAGCCATTTTCCAGGCCTGCTTGTTACGCTTCCGTCCAATAATGATGACCACGCTGGCGGCGCTGTTCGGCGCACTGCCATTGGTGTTATCTGGCGGAGACGGTTCGGAATTACGGCAGCCGCTGGGGATAACCATTGTCGGCGGTTTGGTCATGAGCCAGCTTCTGACGCTCTATACCACGCCAGTGGTGTACCTCTTTTTCGACCGTCTGCGGCTGCGTTTTTCGCGTAAAAATAGCAAACCGGTAGTAGAGATATGA	MRFFALFIYRPVATILIAAAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPGGMPSRPTYRKANPSDAPIMILTLTSESWSQGKLYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDEVREAIDSANVRRPQGAIEDSVHRWQIQTNDELKTAAEYQPLIIHYNNGAAVRLGDVASVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDGIRAKLPELRAMIPAAIDLQIVQDRSPTIRASLQEVEETLAISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVISMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLVVSLTLTPMMCGWMLKSSKPRTQPRKRGVGRLLVALQQGYGTSLKWVLNHTRLVGVVFLGTVALNIWLYIAIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVNNVTGFTGGSRVNSGMMFITLKPRGERKETAQQIIDRLRVKLAKEPGARLFLMAVQDIRVGGRQANASYQYTLLSDSLAALREWEPKIRKALSALPQLADVNSDQQDNGAEMNLIYDRDTMSRLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYSQDISALEKMFVINRDGKAIPLSYFAQWRPANAPLSVNHQGLSAASTIAFNLPTGTSLSQATEAINRTMTQLGVPPTVRGSFSGTAQVFQQTMNSQLILIVAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRSGGLTPEQAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKNSKPVVEI	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	100.10	gnl|BL_ORD_ID|1241|hsp_num:0	1315		
DAAGAT010000003.1_216 # 221534 # 222256 # 1 # ID=3_216;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.539	DAAGAT010000003.1_216	221534	222256	+	Strict	450	469.544	baeR	96.67	3000828	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTGAATTACCCATTGATGAAAACACGCCGCGCATTTTGATTGTTGAAGATGAACCCAAGCTGGGACAGCTGCTTATTGACTACTTACGCGCGGCGAGTTACGCCCCCACGCTCATCAATCATGGCGACAAGGTACTGCCGTATGTGCGTCAAACGCCGCCGGATCTGATCCTGCTGGATCTGATGCTGCCGGGTACCGATGGTCTGACGCTATGCCGGGAGATTCGCCGTTTTTCCGACATCCCCATTGTGATGGTCACGGCCAAAATCGAAGAGATCGACCGGCTGCTGGGGCTGGAAATCGGCGCCGATGATTATATCTGTAAGCCTTACAGCCCACGCGAAGTCGTGGCCCGCGTGAAAACCATTTTGCGCCGCTGTAAACCGCAGCGCGAACTCCAGCAGCAGGATGCCGAAAGCCCGTTAATGATTGATGAAAGCCGCTTTCAGGCCTCCTGGTGTGGTAAAGCGCTGGATTTAACCCCCGCTGAATTCCGCCTGCTAAAAACCTTATCGCTTGAACCGGGTAAAGTTTTTTCCCGCGAGCAGTTGTTAAACCACCTCTACGACGACTACCGTGTGGTGACCGATCGTACTATCGACAGCCACATTAAAAACCTGCGCCGTAAACTGGAATCGCTGGATGCCGAACAGTCATTTATCCGCGCGGTCTACGGGGTGGGATATCGCTGGGAAGCGGATGCGTGTCGCCTGGTATAA	MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLINHGDKVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLMIDESRFQASWCGKALDLTPAEFRLLKTLSLEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRLV	MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV	100.00	gnl|BL_ORD_ID|1260|hsp_num:0	1337		
DAAGAT010000005.1_122 # 154926 # 158039 # -1 # ID=5_122;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.554	DAAGAT010000005.1_122	154926	158039	-	Strict	1900	2021.51	acrD	94.31	3000491	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCGAATTTTTTTATCGATCGCCCCATTTTTGCCTGGGTGCTGGCTATCCTGTTGTGTCTGACAGGGGCGTTAGCCATTTTTTCTTTACCTGTTGAACAATATCCCGATCTGGCACCGCCCAACGTACGTATTACCGCGAATTATCCGGGAGCGTCGGCGCAAACGCTGGAAAATACCGTAACCCAGGTTATTGAGCAGAATATGACGGGCCTCGATAATCTGATGTACATGTCATCACAAAGCAGCGGAACCGGACAGGCGACCATCACCCTGAGCTTTATTGCGGGAACCGATCCTGATGAGGCGGTTCAGCAGGTGCAAAACCAGTTACAGTCCGCGATGCGTAAACTGCCGCAGGCGGTACAGGATCAAGGCGTCACGGTACGCAAAACGGGCGATACCAATATTTTGACCATCGCTTTCGTCTCTACCGACGGTTCTATGGACAAGCAGGATATCGCCGACTACGTCGCCAGTAATATTCAGGACCCGCTCAGCCGCGTCAACGGCGTGGGCGATATTGACGCTTATGGTTCACAGTACTCTATGCGTATCTGGCTCGATCCGGCCAAATTGAATAGTTTTCAGATGACCACGAAAGACGTGACCGATGCGATTGAGTCGCAGAATGCGCAAATCGCCGTCGGGCAGCTTGGCGGTACGCCTTCGGTCGACAAGCAGGCGCTGAACGCCACCATTAATGCGCAGTCACTGCTGCAAACGCCGCAACAATTTCGCGATATCACCCTGCGCGTTAATCAGGACGGTTCCGAGGTCAAACTGGGCGATGTCGCCACCGTGGAGCTGGGGGCGGAAAAATATGACTACCTCAGCCGTTTTAACGGCAATCCGGCTTCCGGTCTTGGCGTTAAGCTGGCCTCCGGCGCGAACGAAATGGCGACCGCGAAGCTGGTACTGGATCGCCTCAACGAGCTGGCGCAGTACTTCCCTCACGGCCTGGAATACAAGATCGCGTATGAAACCACCTCCTTTGTCAAAGCCTCGATTATCGATGTGGTCAAAACGTTGCTGGAAGCTATCGCGCTGGTTTTCCTGGTGATGTATCTGTTCCTGCAAAACTTTCGCGCCACGCTAATTCCGACGATCGCCGTGCCGGTAGTATTAATGGGCACCTTCTCCGTGCTTTACGCGTTTGGCTACAGTATTAACACATTAACCATGTTCGCGATGGTGCTGGCGATCGGGCTCCTGGTCGACGATGCCATCGTGGTGGTGGAAAACGTCGAACGTATCATGAGCGAAGAAGGGCTCACGCCGCGTGAAGCGACGCGCAAATCCATGGGACAAATCCAGGGGGCGCTGGTCGGTATCGCGATGGTGCTGTCTGCGGTATTCGTGCCGATGGCGTTCTTTGGCGGTACCACCGGGGCGATTTATCGTCAGTTTTCTATTACCATTGTCTCGGCAATGGTGCTGTCGGTGCTGGTCGCCATGATCCTGACGCCAGCGTTGTGCGCAACGTTATTAAAACCGCTGCACAAAGGCGAGCAGCACGGGCAACGCGGATTTTTCGGCTGGTTTAACCGTACCTTCAATCGTAATGCCGAACGTTATGAGAAAGGCGTAGCGAAAATTTTGCATCGCAGCCTGCGCTGGATTCTGATTTATGTTCTGTTGCTTGGCGGCATGGTGTTCCTGTTTTTGCGCCTTCCCACCTCCTTTCTGCCGCAGGAAGATCGGGGCATGTTCACTACGTCTATCCAGCTACCGAGCGGTTCTACGCAACAGCAGACCCTGAAAGTCGTTGAAAAGGTTGAAAACTATTACTTCACCCATGAGAAAGACAACATTATGTCGGTCTTCTCGACGGTAGGTTCCGGCCCTGGCGGGAATGGGCAAAACGTCGCGCGCATGTTTGTTCGCTTGAAAGACTGGGACGCGCGCGATCCCACCACCGGCTCCTCGTTCGCCATTATTGAGCGGGCGACAAAAGCATTTAACCAGATTAAAGAAGCTCGCGTCTTCGCCAGCAGCCCGCCGGCAATTAGCGGTCTGGGCAGCTCCGCCGGTTTTGATATGGAATTACAGGATCACGCCGGAGCAGGCCATGACGCGCTGATGGCCGCACGAGATCAACTCATTGAGCTGGCCGGGAAAAACAGTTCCTTGACCCGCGTGCGCCACAACGGCCTGGACGACAGCCCGCAACTGCAAATTGATATTGACCAACGAAAAGCGCAGGCGCTGGGCGTATCGATTGACGATATCAACGACACCCTGCAAACAGCCTGGGGATCGAGCTACGTCAACGACTTTATGGACCGGGGCCGCGTGAAGAAGGTCTATGTTCAGGCCGCAGCGAAATATCGTATGTTGCCGGATGATATTAATCTTTGGTATGTCCGTAACAAAGATGGCGGCATGGTCCCCTTCTCCGCCTTCGCCACCTCGCGCTGGGAAACCGGATCGCCGCGTCTGGAACGCTATAACGGCTATTCGGCGGTAGAAATTGTCGGAGAGGCCGCGCCGGGGGTCAGTACCGGGACGGCGATGGATGTCATGGAGTCGTTGGTGCATCAGCTACCGGGCGGTTTTGGCCTGGAATGGACAGCCATGTCTTACCAGGAACGGCTCTCCGGCGCGCAGGCGCCCGCGCTGTACGCTATTTCGCTATTAGTCGTCTTCCTGTGTCTGGCGGCATTGTATGAAAGCTGGTCGGTGCCCTTCTCGGTGATGCTGGTTGTGCCGCTCGGGGTCATCGGCGCGTTACTCGCCACCTGGATGCGCGGGCTGGAAAACGATGTTTACTTCCAGGTGGGGCTGTTGACCGTTATCGGCCTCTCGGCGAAAAACGCGATTCTGATTGTGGAATTCGCCAACGAAATGAATCAGAAGGGACACGCGCTGTTAGACGCCACGCTGTACGCCAGCCGCCAGCGCCTGCGACCGATACTGATGACTTCGCTGGCGTTTATCTTTGGCGTATTGCCGATGGCCACCAGCACCGGGGCAGGCTCGGGTAGCCAACATGCTGTCGGAACCGGCGTGATGGGGGGAATGATCTCAGCAACCGTTCTGGCTATCTTCTTTGTACCCCTGTTTTTCGTGCTGATACGTCGCCGCTTCCCGCTGAAGCCGCGCCCGGAATAA	MANFFIDRPIFAWVLAILLCLTGALAIFSLPVEQYPDLAPPNVRITANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQATITLSFIAGTDPDEAVQQVQNQLQSAMRKLPQAVQDQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTTKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPQQFRDITLRVNQDGSEVKLGDVATVELGAEKYDYLSRFNGNPASGLGVKLASGANEMATAKLVLDRLNELAQYFPHGLEYKIAYETTSFVKASIIDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVSAMVLSVLVAMILTPALCATLLKPLHKGEQHGQRGFFGWFNRTFNRNAERYEKGVAKILHRSLRWILIYVLLLGGMVFLFLRLPTSFLPQEDRGMFTTSIQLPSGSTQQQTLKVVEKVENYYFTHEKDNIMSVFSTVGSGPGGNGQNVARMFVRLKDWDARDPTTGSSFAIIERATKAFNQIKEARVFASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARDQLIELAGKNSSLTRVRHNGLDDSPQLQIDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDVMESLVHQLPGGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHALLDATLYASRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLIRRRFPLKPRPE	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	100.00	gnl|BL_ORD_ID|1343|hsp_num:0	1427		
DAAGAT010000005.1_125 # 162520 # 163818 # -1 # ID=5_125;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.461	DAAGAT010000005.1_125	162520	163818	-	Strict	500	678.707	Escherichia coli ampC1 beta-lactamase	72.92	3004611	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGAAATTTACTCTCGTTGCGACGGTTCTACTGACGTTTTCCCTTTCAGCTTTTGCCGTTGAGTATCCGGTATTGACCACCGCGAGCCCTGAACAGGTGGGGTTTGATAGCCAAAAACTTCACCGACTTGATGGCTGGATTCAAAATCAAATTGATGCCGGATATCCCAGCATCAATCTTCTGGTGATAAAAGATAATCATATTGTTCTACAAAAAGCCTGGGGCTATGCCAAAAAATATGACGGTTCCACGCTGTTAGCCCATCCCATTCGGGCGACCACTAACACGATGTATGATCTGGCTTCAAACACAAAAATGTATGCCACTAACTTCGCATTGCAAAAACTAGTGTATGAAGGAAAAATAGATGTCAATGATTTGGTATCAAAATATATCCCCGGCTTTAAGGATATGCCTGGGGATAAAATAAAAGGCAAAGATAAACTCCGCATTATTGATATTCTTCATCACGTCGCGGGCTTTCCTGCCGACCCACAATATCCCAATAAAAACGTCGCCGGTAAATTATTTTCACAGAGTAAAAGCACTACTCTGGAGATGATTAAAAAGACACCGCTGGAATATCAACCTGGGTCGAAGCATATCTACAGCGACGTGGATTATATGATTCTTGGTTTTATCATTGAATCGATAACGGCAATGCCATTAGATCGCTACGTCGAAACCACCATTTATAAACCGCTCGGATTAAAACATACCGTCTTTAACCCGCTGATGAAAGGCTTCACGCCGCCGCAAATCGCCGCAACGGAACTACACGGCAATACGCGTGACGGCGTGATTCATTTCCCCAATATTCGCACCAATACACTATGGGGCCAGGTACATGATGAAAAAGCCTGGTACTCAATGGGCGGCGTTTCAGGACACGCCGGACTGTTTTCTGATACCCATGATATGGCTGTGTTAATGCAAGTCATGCTCAATGGGGGCGGCTACGGTAACGTGAAGCTATTCGACGACAAAACAGTTGCGCAGTTTACTCGCCGCTCGCCAGAAGACGCTACCTTTGGTCTGGGGTGGCGCGTTAACGGCAACGCCTCAATGACCCCCACGTTCGGGGTATTAGCCAGTCCGCAAACGTATGGACATACCGGATGGACCGGCACGCTGACGTCTATCGATCCGGTTAATCATATGGCGATTGTGATTTTAGGTAACAGGCCGCACTCGCCGGTAGCAAATCCTAAAGTGAATCCGAATGTTTTTGTCAGTGGATTATTACCTGCGGCGACGTATGGCTGGATTGTTGACCAGATATATGGTTCCTTAAAATAA	MKFTLVATVLLTFSLSAFAVEYPVLTTASPEQVGFDSQKLHRLDGWIQNQIDAGYPSINLLVIKDNHIVLQKAWGYAKKYDGSTLLAHPIRATTNTMYDLASNTKMYATNFALQKLVYEGKIDVNDLVSKYIPGFKDMPGDKIKGKDKLRIIDILHHVAGFPADPQYPNKNVAGKLFSQSKSTTLEMIKKTPLEYQPGSKHIYSDVDYMILGFIIESITAMPLDRYVETTIYKPLGLKHTVFNPLMKGFTPPQIAATELHGNTRDGVIHFPNIRTNTLWGQVHDEKAWYSMGGVSGHAGLFSDTHDMAVLMQVMLNGGGYGNVKLFDDKTVAQFTRRSPEDATFGLGWRVNGNASMTPTFGVLASPQTYGHTGWTGTLTSIDPVNHMAIVILGNRPHSPVANPKVNPNVFVSGLLPAATYGWIVDQIYGSLK	MKRTMLYLSLLAVSCSVSAAKYPVLTESSPEKAGFNVERLNQMDRWISQQVDVGYPSVNLLIIKDNQIVYRKAWGAAKKYDGSVLMEQPVKATTGTLYDLASNTKMYATNFALQKLMSEGKLHPDDRIAKYIPGFADSPNDTIKGKNTLRISDLLHHSGGFPADPQYPNKAVAGALYSQDKGQTLEMIKRTPLEYQPGSKHIYSDVDYMLLGFIVESVTGQPLDRYVEESIYRPLGLTHTVFNPLLKGFKPQQIAATELNGNTRDGVIHFPNIRTSTLWGQVHDEKAFYSMGGVSGHAGLFSNTGDIAVLMQTMLNGGGYGDVQLFNAETVKMFTTSSKEDATFGLGWRVNGNATMTPTFGTLASPQTYGHTGWTGTVTVIDPVNHMTIVMLSNKPHSPVADPQKNPNMFESGQLPIATYGWVVDQVYAALKQK	99.54	gnl|BL_ORD_ID|1971|hsp_num:0	3306		
DAAGAT010000007.1_49 # 52749 # 53426 # 1 # ID=7_49;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.563	DAAGAT010000007.1_49	52749	53426	+	Strict	400	426.402	kdpE	92.41	3003841	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	GTGACAAACGTTCTGATTGTTGAAGATGAACAGGCCATCCGCCGCTTTCTGCGCGCCGCGCTGGAAGGCGACGGCCTGCGCGTGTATGAAGCTGAAACATTACAACGTGGTTTACTGGAAGCCGCCACGCGAAAGCCCGATCTGATTATTCTCGATCTCGGCCTGCCGGACGGCGACGGAATCGATTTTATTCGCGACCTGCGTCAGTGGAGCGCAATACCGGTGATTGTCCTTTCCGCCCGCAGCGAAGAAAGCGATAAGATTGCCGCGCTTGACGCCGGAGCTGATGATTACCTGAGCAAGCCATTCGGCATTGGCGAGTTGCAGGCGCGTTTGCGTGTCGCGCTGCGACGGCACGCCGCCAGCCCTTGCGCCGATCCGATCGTCCGCTTTTCCGGCGTGACGGTCGATCTCGCCGCACGGTTAATCCACCGTGGCGACGAAGAAATCCATCTGACGCCGATTGAGTTCCGCCTGCTGGCGGTATTACTCAATAATGCCGGCAAGGTATTAACCCAACGGCAGTTATTAAACCAGGTCTGGGGCCCTAACGCCGTGGAGCATAGCCACTATTTGCGCATCTATATGGGACATTTACGCCAGAAACTGGAACAAGATCCCACCCGCCCACGCCATTTTATTACCGAAACTGGAATTGGCTATCGCTTTATGCCGTGA	MTNVLIVEDEQAIRRFLRAALEGDGLRVYEAETLQRGLLEAATRKPDLIILDLGLPDGDGIDFIRDLRQWSAIPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHAASPCADPIVRFSGVTVDLAARLIHRGDEEIHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPTRPRHFITETGIGYRFMP	MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML	100.00	gnl|BL_ORD_ID|2168|hsp_num:0	2331		
DAAGAT010000007.1_158 # 174499 # 174717 # -1 # ID=7_158;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.557	DAAGAT010000007.1_158 	174499	174717	-	Strict	500	22.7126	TEM-60	100.0	3000929	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGGAATTCAGTAATCCCTTCGATAATCCGCAGGGACAGTTTTACATCCTGCAAAATGCGCAGCGTCAATTCAGCCTTTGGCCAGCGGCGTGCGCGCTTCCCGCAGGATGGGACGTGGTATGCGAACCGCAATCGCAGGACGCGTGCCAGCAGTGGCTTAATACGCGCTGGACAACACTGAATCCGGCGCATTATGCCGATAAGCAGGAGGCGAAATGA	MEFSNPFDNPQGQFYILQNAQRQFSLWPAACALPAGWDVVCEPQSQDACQQWLNTRWTTLNPAHYADKQEAK	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDPNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTMPAAMRTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRCALPAGWLIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	25.17	gnl|BL_ORD_ID|1927|hsp_num:0	2040	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000008.1_38 # 37514 # 38671 # 1 # ID=8_38;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.528	DAAGAT010000008.1_38	37514	38671	+	Strict	500	736.102	Escherichia coli ampH beta-lactamase	91.43	3004612	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	TTGAAACGTAGTCTGCTTTTTACTGCCATGCTGTTTGCGGCATCACTTACTTCTGTCCAGGCGGCTCAGCCGATTGCCGATCCGGTTTTTGCCTCTGATATCGTTGATCGTTATGCCGAGCATATCTTTTATGGTAGCGGCGCCACGGGCATGGCGCTGGTGGTGATCGACGGCAATCAACGCGTGTTTCGTAGTTTCGGTGACACCAGACCGGGAAATAATGTTCGTCCACAGCTTGATTCGGTCATTCGTATCGCTTCTCTCACCAAGCTCATGACCAGTGAAATGTTGGTAAAATTGCTCGATCAGGGAACGGTAAAATTAAACGATCCTCTCAGCAAATATGCGCCTCCCGGCGCGCATGTCCCGACGTATCAAGGCACGCCGATTACGTTGGTCAACTTAGCAACCCACACCAGCGCGCTTCCGCGAGAACAGCCAGGCGGCGCGGCGCATCGTCCGGTATTTGTCTGGCCAACCCGCGAACAACGCTGGAACTGGCTCTCCACAGCAACGTTAAAAGTCGCGCCCGGTTCGCAGGCGGCCTATTCCAATCTGGCGTTCGACCTGTTAGCCGACGCGCTGGCGACCGCCTCCGGCAAACCTTATACGCAACTGTTTGAAGAAAAGATTACTCGCCCGCTGGGAATGAAAGACACCACGTTTACCCCTTCTCCCGATCAGTGTAAGCGTCTGATGGTGGCAGAAAAAGGCGCAAGCCCCTGTAATAATACGCTGGCTGCCATTGGCAGCGGTGGGGTCTATTCTACGCCAGGAGATATGATGCGCTGGATGCAACAGTATCTGTCGTCAGATTTCTATCACCGTAGCCAACAGGCCGATCGTATGCAAACGTTGATTTATCAGCGCACACAGTTAAAGAAAATCATTGGGATGGACGTACCGGGTAAAGCCGACGCGCTCGGTCTGGGCTGGGTCTATATGGCGCCAAAAGACGGACGTCCTGGCATTATCCAGAAAACAGGAGGCGGCGGCGGTTTTATTACCTATATGGCGATGATCCCACAATATAATATTGGCGCTTTTGTGGTCGTAACCCGTTCCCCCCTCACGCGTTTTACCAATATGAGCGACGGGATTAACGATTTGGTTACTGAGCTAAGCGGCAATAAACCGATTGCTATTCCCGCATCCTGA	MKRSLLFTAMLFAASLTSVQAAQPIADPVFASDIVDRYAEHIFYGSGATGMALVVIDGNQRVFRSFGDTRPGNNVRPQLDSVIRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGAHVPTYQGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWNWLSTATLKVAPGSQAAYSNLAFDLLADALATASGKPYTQLFEEKITRPLGMKDTTFTPSPDQCKRLMVAEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYHRSQQADRMQTLIYQRTQLKKIIGMDVPGKADALGLGWVYMAPKDGRPGIIQKTGGGGGFITYMAMIPQYNIGAFVVVTRSPLTRFTNMSDGINDLVTELSGNKPIAIPAS	MKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS	100.00	gnl|BL_ORD_ID|2083|hsp_num:0	3307		
DAAGAT010000008.1_59 # 66152 # 66616 # -1 # ID=8_59;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.540	DAAGAT010000008.1_59	66152	66616	-	Perfect	290	319.316	golS	100.0	3000504	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; penem; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACATCGGTAAAGCAGCTAAAGCATCGAAAGTTTCGGCCAAAATGATTCGCTACTATGAACAGATTGGTCTGATTCCCGCGGCAAGTCGGACGGATTCCGGCTATCGGGCCTATACCCAGGCTGATGTTAATCAATTGCATTTTATACGCCGCGCGCGCGATCTCGGCTTTTCAGTTGCTGAAATCAGCGACTTACTGAATCTTTGGAATAACCAGTCGAGGCAAAGCGCTGACGTCAAACGCCTGGCGCAGACGCACATTGATGAACTGGACAGACGTATCCAGAACATGCAGCACATGGCGCAAACCCTCAAAGCGCTGATTCACTGCTGCGCCGGCGACGCGCTGCCAGATTGCCCCATTCTGCATACGCTTGGACAACCTGACGATAGCGAGCCGGAGGCGCGTACCGGAGCGGTATTGCGCCGTCCTCGTCGCCATGGACTGGCAAAGCGTCTGTAA	MNIGKAAKASKVSAKMIRYYEQIGLIPAASRTDSGYRAYTQADVNQLHFIRRARDLGFSVAEISDLLNLWNNQSRQSADVKRLAQTHIDELDRRIQNMQHMAQTLKALIHCCAGDALPDCPILHTLGQPDDSEPEARTGAVLRRPRRHGLAKRL	MNIGKAAKASKVSAKMIRYYEQIGLIPAASRTDSGYRAYTQADVNQLHFIRRARDLGFSVAEISDLLNLWNNQSRQSADVKRLAQTHIDELDRRIQNMQHMAQTLKALIHCCAGDALPDCPILHTLGQPDDSEPEARTGAVLRRPRRHGLAKRL	100.00	gnl|BL_ORD_ID|35|hsp_num:0	44		
DAAGAT010000008.1_61 # 69193 # 70419 # 1 # ID=8_61;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.607	DAAGAT010000008.1_61	69193	70419	+	Strict	770	802.742	mdsA	98.28	3000789	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; penem; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTAGAACATTCAAAATTATGTTGATAGCCGGCGTCATCGCCGCCATCGGGGGCGTGATTTACATGGCCGGCGAAGCACTATGGGATAAAGACAACGCCGTCGGCCCCCCGGCCAGCGCGCCGCCTCCACCGTCGGTACCGGTTGCTAAAGCCCTTAGCCGTACACTCGCGCCTACGGCGGAATTCACCGGTTTTCTGGCCGCGCCGGAGACCGTGGAGCTGCGTTCGCGCGTGGGAGGAACCCTTGACGCCGTCAGCGTTCCGGAAGGACGTCTGGTAAGCCGCGGACAACTGCTGTTCCAGATCGATCCGCGCCCGTTCGAGGTCGCCCTCGACACCGCCGTCGCGCAATTACGTCAGGCTGAAGTACTGGCCCGCCAGGCGCAGGCGGATTTCGATCGCATTCAACGACTGGTCGCCAGCGGCGCCGTATCACGTAAAAACGCTGACGATGTCACCGCCACGCGTAATGCGCGACAGGCGCAGATGCAATCGGCCAAAGCCGCCGTCGCCGCAGCGCGCCTTGAACTCTCCTGGACCCGTATTACCGCGCCCATTGCCGGACGCGTTGACCGCATACTGGTGACCCGGGGCAACCTGGTCAGCGGCGGCGTAGCGGGTAACGCCACGCTTTTGACGACTATCGTGTCTCACAATCCCATGTATGTGTATTTCGATATTGACGAAGCCACCTGGCTGAAGGCGTTACGGCATACCCGCTCCGACAAAAATCCACCGGTAGTCAACATGGGGTTAACCACCGATAACGGGCTGCCTTATCAGGGCGTACTCGACTTTATGGGCAATCAGATGAACCGCAGCACCGGCACTATCCGGGCGCGCGCCGTGATTCCTGACCCCGACGGAATGCTTTCTCCCGGCCTGTTTGCCCGAATCAGTTTGCCCATCGGCGAGCCGCGGGAAACCGTGCTGATTGACGATCTGGCGGTGAGCGCCGATCAGGGCAAAAACTATGTGCTGATCGTCGGCAAGGAGAATCAGGTGGAGTATCGTCCGGTTGAGCTGGGACAAATGGTCGATGGACTCCGCGTCGTTACACAGGGAGTACAGCCGGGAGAAAAAATCATCCTCAAGGGGCTGGTGCGTCCTGGCATGACCGTTGCGCCGCGTCTGGTGCCGATGCGGCAGAATATGCCCGAGAAACAGACCGCGACATTGACTAAAGCGGACGGCGACAGCGCGTCGAAGGCGGTGCGCCAATGA	MRRTFKIMLIAGVIAAIGGVIYMAGEALWDKDNAVGPPASAPPPPSVPVAKALSRTLAPTAEFTGFLAAPETVELRSRVGGTLDAVSVPEGRLVSRGQLLFQIDPRPFEVALDTAVAQLRQAEVLARQAQADFDRIQRLVASGAVSRKNADDVTATRNARQAQMQSAKAAVAAARLELSWTRITAPIAGRVDRILVTRGNLVSGGVAGNATLLTTIVSHNPMYVYFDIDEATWLKALRHTRSDKNPPVVNMGLTTDNGLPYQGVLDFMGNQMNRSTGTIRARAVIPDPDGMLSPGLFARISLPIGEPRETVLIDDLAVSADQGKNYVLIVGKENQVEYRPVELGQMVDGLRVVTQGVQPGEKIILKGLVRPGMTVAPRLVPMRQNMPEKQTATLTKADGDSASKAVRQ	MRRTFKIMLIAGVIAAIGGVIYMAGEALWDKDNAVGPPASAPPPPSVPVAKALSRTLAPTAEFTGFLAAPETVELRSRVGGTLDAISVPEGRLVSRGQLLFQIDPRPFEVALDTAVAQLRQAEVLARQAQADFDRIQRLVASGAVSRKNADDVTATRNARQAQMQSAKAAVAAARLELSWTRITAPIAGRVDRILVTRGNLVSGGVAGNATLLTTIVSHNPMYVYFDIDEATWLKALRHTRSDKNPPVVNMGLTTDNGLPYQGVLDFMGNQMNRSTGTIRARAVIPDPDGMLSPGLFARISLPIGEPRETVLIDDLAVSADQGKNYVLIVGKENQVEYRPVELGQMVDGFRVVTQGVLPGEKIILKGLVRPGMTVAPRLVPMRQNVTDKQTATLTKADGDSAPKAVRQ	100.00	gnl|BL_ORD_ID|400|hsp_num:0	429		
DAAGAT010000008.1_62 # 70416 # 73583 # 1 # ID=8_62;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.566	DAAGAT010000008.1_62	70416	73583	+	Strict	2090	2119.74	mdsB	99.91	3000790	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; penem; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAATTCACCCACTTTTTCATCGCACGGCCCATCTTCGCCATCGTCCTGTCGCTGTTAATGCTGCTGGCTGGCGCTATCGCCTTTTTAAAACTGCCGCTGAGTGAATATCCGGCCGTTACGCCGCCCACGGTACAGGTTAGCGCCAGCTACCCCGGCGCTAACCCGCAAGTGATTGCCGATACGGTAGCCGCGCCGCTGGAACAGGTGATCAACGGCGTTGACGGCATGTTGTATATGAATACCCAGATGGCCATTGATGGTCGCATGGTTATCTCTATCGCCTTCGAACAGGGAACCGATCCTGATATGGCGCAAATTCAGGTGCAAAACCGGGTATCCCGCGCGCTGCCTCGCCTGCCCGAAGAAGTCCAGCGAATTGGCGTTGTAACGGAGAAAACGTCCCCCGATATGTTGATGGTGGTTCATCTTGTCTCGCCGCAAAAACGCTATGACTCGCTTTACCTGTCTAACTTCGCCATCCGGCAGGTTCGCGACGAACTGGCCCGTTTACCCGGCGTCGGCGATGTTCTCGTCTGGGGCGCGGGCGAGTACGCCATGCGCGTCTGGCTGGACCCGGCGAAAATCGCCAACCGCGGTCTTACCGCCAGTGATATCGTTACGGCGTTGCGGGAACAAAACGTACAGGTCGCCGCCGGTTCCGTCGGGCAACAGCCGGAGGCCTCCGCCGCTTTTCAGATGACGGTAAACACGCTGGGCCGCCTGACCAGCGAAGAACAGTTCGGCGAGATTGTGGTAAAAATCGGCGCTGACGGCGAGGTGACGCGTCTGCGTGATGTCGCCCGCGTCACGCTGGGCGCAGATGCCTATACGCTGCGCAGTTTACTGAATGGCGAAGCGGCGCCAGCGTTACAGATTATTCAAAGTCCGGGCGCCAATGCGATTGACGTTTCTAACGCGATTCGCGGCAAAATGGATGAGTTGCAGCAAAACTTCCCGCAGGATATCGAATACCGGATTGCCTATGATCCTACGGTCTTCGTGCGCGCATCGCTACAATCGGTGGCGATTACGTTGCTGGAAGCCCTCGTGCTGGTCGTCCTTGTCGTGGTGATGTTCCTGCAAACCTGGCGGGCGTCCATTATTCCTCTGGTGGCGGTTCCCGTTTCGCTGGTCGGCACCTTTGCCTTGATGCACCTGTTTGGCTTTTCGCTGAATACGCTTTCGCTGTTTGGTTTGGTCCTGTCGATAGGTATCGTTGTCGATGACGCCATCGTTGTGGTCGAAAACGTGGAACGGCATATCTCGCAGGGCAAAAGTCCCGGAGAGGCGGCAAAGAAGGCGATGGATGAAGTCACTGGTCCCATTCTTTCTATTACCTCGGTGCTAACGGCGGTCTTTATCCCTTCCGCATTCCTGGCGGGCCTGCAGGGTGAGTTTTATCGTCAGTTCGCGTTGACCATCGCTATTTCGACCATCCTTTCGGCCATTAACTCGCTGACGCTCTCCCCTGCGCTGGCTGCCATTTTGCTAAGACCGCACCACGATACTGCGAAGGCTGACTGGCTAACGCGGTTGATGGGCACGGTCACTGGCGGTTTTTTCCATCGCTTTAACCGTTTCTTCGACAGCGCGTCGAACCGCTATGTTAGCGCCGTCCGTCGGGCCGTGCGCGGCAGCGTCATTGTGATGGTGCTCTATGCTGGCTTTGTGGGGCTGACCTGGCTTGGCTTCCATCAGGTGCCGAACGGGTTTGTGCCTGCGCAGGATAAATACTATCTCGTCGGCATCGCCCAGCTCCCAAGCGGCGCATCGTTGGATCGCACAGAGGCGGTCGTGAAACAGATGTCCGCTATCGCGCTGGCGGAACCCGGCGTTGAAAGCGTCGTCGTCTTCCCCGGTCTGTCGGTTAACGGCCCGGTAAATGTGCCAAATTCGGCGCTGATGTTCGCCATGCTGAAACCCTTTGACGAGCGTGAAGATCCTTCGCTTTCCGCTAACGCTATCGCCGGAAAGCTAATGCACAAATTTAGCCACATTCCCGACGGATTTATTGGCATCTTCCCGCCACCGCCGGTTCCAGGGCTTGGCGCGACGGGCGGCTTTAAATTGCAGATTGAAGATCGTGCGGAACTGGGATTTGAAGCGATGACAAAGGTGCAAAGCGAGATTATGTCTAAGGCGATGCAGACGCCCGAACTGGCCAATATGCTGGCCAGTTTCCAGACAAACGCCCCGCAATTACAGGTGGATATCGACCGGGTAAAGGCGAAATCAATGGGGGTATCGCTCACCGACATCTTTGAAACGTTGCAAATTAACCTCGGCTCGCTTTACGTCAACGATTTCAACCGATTTGGCCGTACCTGGCGGGTGATGGCGCAGGCCGATGCGCCATTCCGTATGCAACAAGAGGATATCGGCCTGCTTAAAGTCCGCAATGCGAAGGGCGAGATGATCCCGCTTAGCGCTTTCGTCACGATTATGCGCCAGTCGGGGCCGGACAGAATCATCCATTACAACGGCTTCCCCTCGGTAGATATTAGCGGTGGACCGGCTCCGGGCTTCTCCTCCGGACAGGCGACGGACGCAATTGAAAAGATCGTGCGTGAAACGTTACCGGAAGGGATGGTCTTCGAATGGACCGATCTGGTTTATCAGGAAAAACAGGCCGGCAATTCTGCGCTTGCTATCTTTGCGCTGGCGGTGCTGTTGGCCTTCCTGATCCTGGCGGCGCAGTACAACAGTTGGTCGCTGCCCTTTGCCGTCCTGCTTATTGCGCCTATGTCATTACTCTCAGCCATTGTCGGCGTGTGGGTATCTGGCGGAGATAACAATATCTTTACGCAGATTGGTTTCGTGGTGCTGGTCGGCCTGGCGGCCAAGAACGCCATTTTGATTGTCGAGTTTGCCCGCGCCAAAGAACACGACGGCGCAGACCCGCTGACCGCCGTACTGGAAGCGTCCCGCCTGCGTCTGCGTCCTATCCTGATGACCTCATTCGCCTTTATCGCAGGCGTAGTACCGCTGGTACTCGCGACGGGTGCCGGCGCGGAAATGCGACATGCGATGGGCATCGCCGTGTTTGCCGGCATGTTGGGCGTCACGCTCTTCGGCCTGTTATTGACGCCTGTGTTTTACGTGGTGGTTCGCAGGATGGCATTAAAGCGTGAGAACCGCGTTGATTCACATGATCAGCAAGCATAA	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRTWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	100.00	gnl|BL_ORD_ID|1301|hsp_num:0	1385		
DAAGAT010000008.1_63 # 73600 # 75057 # 1 # ID=8_63;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.595	DAAGAT010000008.1_63	73600	75057	+	Strict	940	966.837	mdsC	99.18	3000791	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; penem; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGATCACTTTTACAGGCTATCGGCAGACCGCCACGCTGGCGACGCTTGCTTTCGTCACCACGCTTGCTGGCTGTACGATGGCGCCGAAGCACGAACGCCCCACATCGCCGACTGCGGTGGTCTATCCCTACGCAACGTCAACCGTTTCTGGCGCGCCGGATGCCGCTGACATTGGCTGGCGTGATTTCTTCCACGATCCGCTTCTACAGGAACTGATCGCGATCGCGTTACGCAATAATCGGGATTTACGCAAGGCAGGGCTCAATGTTGAAGCCGCCCGGGCGTTATACCGTATTCAGCGCGCGGAGATGCTGCCGACGCTCGGCATCGCCACCGCCATGGACGCCGGTCGCACTCCCGCCGATCTCAGCGTCATGGACGAGTCTGAGATTAACCGACGCTACGAGGCGGCTGGGGCGACGACGGCCTGGGAACTGGATCTCTGGGGGCGAGTGCGAAGCCTTAGCGACCAGGCATTAGCCGCCTATATGGCGCTTGATGAGACGTACATTGCGGCGCGAATGAGCCTGGTTTCCGAAGTCGCCAGCGCCTGGCTGACGCTACGGGCTGACCGGGAGCTGCTGCGCTTAACCGAAGATACGCTGGCCGCGCAAAAAAGTTCATACACATTGACAACCCAGCTTGCCCGGACAGGCAACGCCACACAGCTCGATCTGCGTATGGCGGAGATCGCGCTGCGTTCTGCCGAAATCAATCGCGCGGCGTATACGCGACAGTTGGCGCGGGATCGTAACGCGCTTGAATTGCTGTTGGGCCAGCCGCTCACGCCTGAACTGTCGCGTCGACTAAACGAGGCGGTCACGCTTACGGAAGGCGCGATCCCGACCACATTGCCAGGCGGATTACCGTCAGATCTGCTGGTACGCCGCCCGGATATTCGCGCCGCCGAGTACAGGCTGCGTGGCGCAAACGCCCGGATAGGCGCAGCGCGCGCCGCCTTCTTCCCGACCATCAGCCTGACAGGCGCGGCGGGAACGGCCAGCGCGTCTCTTAGCGGACTCTTTGAACCGGGATCGGGAAGCTGGCGTTTTCTACCGCAAATCACCTTGCCTCTCTTTCACGGCGGCGCATTACGCGCTGACCTGGATAGGGCGCATGTCCAAAAACAGATTGAAATCGCCAGGTATGAAAACGTTATTCAGCAAGCCTTTCGCGACGTGGCGGATGGTCTGGCGGGACAGCGTACGCTGAATGACCAGGTGCAATCAGAACAACGCGCGGTTGAAGCCAGCCAAATCGCCTATGAGCTGGCCGGACTCCGTTTTCAGGAAGGCGTCGATGACTACCTTACGCTGCTTGATACCCATCGTATGCTTTATGGCGCGCAACAGCGCCTGGTACGCACACGGCTCATGCAACAGCTGAATATCATTAATCTGTATAAAGCATTAGGCGGCGGTTGGCGGGAATACAGCGAGAAAAAGCAAGGTTAG	MKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPTSPTAVVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDAGRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGAAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG	MRTALIRMISKHNDGNGIMKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG	96.42	gnl|BL_ORD_ID|1113|hsp_num:0	1180		
DAAGAT010000010.1_86 # 101301 # 101831 # 1 # ID=10_86;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.486	DAAGAT010000010.1_86	101301	101831	+	Strict	280	337.806	emrR	93.14	3000516	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGATAGTTCGTTTACGCCCATTGAACAAATGCTAAAATTTCGCGCCAGCCGTCACGAAGACTTTCCTTACCAGGAAATTCTTTTGACTCGTCTTTGTATGCACATGCAAGGCAAGCTCCTGGAAAACCGCAATAAAATGCTGAAGGCTCAAGGGATTAACGAGACGTTGTTTATGGCGTTGATTACGCTGGAGTCTCAGGAAAACCACAGTATTCAGCCGTCTGAATTAAGCTGCGCGCTGGGTTCATCTCGCACCAATGCGACACGCATTGCAGATGAGCTGGAAAAACGCGGCTGGATTGAGCGTCGTGAGAGCGATAACGACCGCCGTTGCCTGCATCTGCAATTAACGGAGAAAGGTCAGGCATTTTTGCAAGAAGTGCTTCCGCCTCAGCATCATTGTCTGCATCAACTCTGGTCATCACTTAGCACAGCCGAAAAAGATCAACTTGAGCACATCACTCGTAAACTCCTGACGCGTCTTGATCAAATGGAGCAGGAAGGCACTGTTCTTGAGGCGCTGCGCTAA	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGQAFLQEVLPPQHHCLHQLWSSLSTAEKDQLEHITRKLLTRLDQMEQEGTVLEALR	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS	100.00	gnl|BL_ORD_ID|1253|hsp_num:0	1330		
DAAGAT010000010.1_87 # 101958 # 103130 # 1 # ID=10_87;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.544	DAAGAT010000010.1_87	101958	103130	+	Strict	675	706.057	emrA	89.74	3000027	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCGCAAATGCGGAGATCCAAACCCCGCAGCAACCGGCTAAGAAGAAAGGCAAGCGCAAAACAGCGCTGCTACTTCTTACCTTGCTCTTTGTTATTATTGCCGTGGCATATGGAATTTATTGGTTTTTAGTATTGCGTCATATTGAAGAGACAGATGATGCTTACGTGGCAGGGAACCAGGTTCAAATCATGGCGCAGGTGTCAGGCAGCGTGACGAAAGTCTGGGCTGATAACACCGACTTTGTAAAAGAGGGCGATGTTCTGGTCACGCTCGATCAGACTGACGCCAAACAAGCGTTTGAAAAAGCCAAAACGGCGCTGGCCTCCAGCGTGCGCCAGACGCACCAGTTGATGATTAACAGCAAGCAGTTGCAGGCGAATATCGACGTGCAAAAAACCGCCCTGGCGCAAGCGCAAAGCGACCTTAACCGTCGTGTGCCGCTGGGTAACGCCAATCTTATTGGCCGTGAAGAGCTGCAACACGCCCGCGATGCCGTCGCCAGCGCGCAGGCACAGCTGGATGTCGCCATTCAACAGTACAATGCCAACCAGGCAATGATACTCAACAGTAATCTGGAAGATCAGCCTGCGGTTCAACAAGCGGCGACCGAAGTGCGTAACGCCTGGCTGGCGCTGGAGCGTACTCGCATCGTCAGTCCAATGACCGGTTATGTTTCCCGCCGCGCCGTCCAGCCTGGCGCGCAAATCAGTCCCACCACGCCGCTGATGGCCGTGGTGCCTGCAACCGATCTGTGGGTGGACGCTAACTTTAAAGAGACCCAATTAGCGAATATGCGCATTGGGCAGCCAGTGACGGTGATTACTGATATTTATGGCGACGACGTAAAATACACCGGTAAAGTCGTCGGTCTGGATATGGGAACAGGCAGCGCCTTCTCCCTGCTGCCCGCGCAAAATGCGACGGGTAACTGGATTAAAGTGGTTCAACGTCTGCCGGTACGCGTCGAACTTGACGCCCGCCAGTTAGAACAACATCCGCTGCGTATTGGTTTATCGACGCTGGTCACCGTGGATACCGCTAATCGCGACGGTCAGGTACTGGCCAGCCAGGTACGAACGACGCCGGTTGCCGAAAGTAACGCACGCGAAATTAATCTCGCGCCGGTCAATAAACTGATCGACGACATCGTACAGGCTAACGCGGGTTAA	MSANAEIQTPQQPAKKKGKRKTALLLLTLLFVIIAVAYGIYWFLVLRHIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAIQQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVDTANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANAG	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	100.00	gnl|BL_ORD_ID|1659|hsp_num:0	1757		
DAAGAT010000010.1_88 # 103147 # 104685 # 1 # ID=10_88;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.565	DAAGAT010000010.1_88	103147	104685	+	Strict	900	947.962	emrB	95.82	3000074	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTCGTCATCATGACGATCGCACTGTCGCTGGCGACATTCATGCAGGTGCTGGACTCCACCATTGCCAACGTGGCGATTCCGACCATCGCCGGGAACCTGGGTTCTTCCCTAAGCCAGGGGACATGGGTTATCACCTCTTTCGGGGTGGCGAACGCTATCTCGATTCCCTTAACCGGCTGGCTGGCGAAACGTTTTGGCGAAGTCAAACTGTTCATGTGGTCGACGGTCGCCTTTGCCGCGGCTTCCTGGGCCTGTGGCGTATCCAGCAGTCTGAATATGCTTATCTTCTTCCGCGTGGTGCAGGGCGTGGTCGCCGGGCCGCTGATTCCGCTCTCGCAAAGCCTGTTGCTGAATAACTATCCGCCTGCAAAGCGCTCCATTGCGCTGGCGCTCTGGTCAATGACCGTCATTGTCGCGCCGATTTGCGGCCCGATTCTGGGGGGCTATATCAGTGATAATTACCACTGGGGATGGATTTTCTTCATCAACGTGCCGATTGGCATCGCCGTCGTCCTGATGACGTTACACACGCTGCGTGGACGTGAAACGCATACCGAACGGCGACGTATTGACGCCGTCGGGCTGGCGCTACTGGTGATTGGCATCGGCAGCCTGCAAATTATGCTCGATCGCGGTAAAGAGCTGGACTGGTTCTCCTCGCAGGAAATTATCATCCTGACCGTGGTCGCCGTCATCGCCATCAGTTTCCTGATCGTCTGGGAACTGACCGACGATCACCCTATCGTCGATCTTTCTCTTTTTAAATCGCGTAACTTCACGATTGGCTGCTTGTGCATCAGCCTTGCCTATATGCTCTATTTCGGCGCCATTGTTCTACTGCCGCAGCTTTTGCAAGAGGTGTACGGCTATACCGCAACGTGGGCAGGTCTGGCGTCGGCGCCAGTCGGCATTATTCCGGTAATTTTGTCGCCGATTATCGGACGCTTCGCGCATAAACTGGATATGCGCAGGCTGGTCACGTTCAGCTTCATTATGTACGCCGTCTGTTTTTACTGGCGCGCCTGGACGTTCGAACCGGGTATGGATTTCGGCGCTTCCGCATGGCCGCAGTTTATTCAGGGATTTGCCGTCGCCTGCTTCTTTATGCCGCTGACCACCATTACGCTCTCCGGGTTACCGCCAGAACGGCTGGCAGCGGCATCAAGCCTGTCGAACTTCACGCGAACGCTGGCAGGTTCAATTGGCACCTCGATTACCACCACTATGTGGACCGATCGTGAGTCGCTACACCATGCTCAGCTCACGGAGTCGGTTACGGCGTATAATCCAAACGCTCAGGCTATGTACGATAAACTGGAAGGCTTAGGGATGACGCACCAACAGGCGTCAGGCTGGATAGCCCAGCAAATCACGAATCAGGGGCTGATTATTTCCGCCAACGAAATCTTCTGGATGTCGGCGGGGATCTTCCTGGTGCTGCTCGGCCTGGTGTGGTTCGCCAAACCGCCCTTCGGTGCGGGCGGCGGCGGTGGCGGCGCGCACTAA	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRFGEVKLFMWSTVAFAAASWACGVSSSLNMLIFFRVVQGVVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGIAVVLMTLHTLRGRETHTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVIAISFLIVWELTDDHPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTDRESLHHAQLTESVTAYNPNAQAMYDKLEGLGMTHQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH	100.00	gnl|BL_ORD_ID|1748|hsp_num:0	1847		
DAAGAT010000011.1_138 # 142025 # 142846 # 1 # ID=11_138;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.536	DAAGAT010000011.1_138	142025	142846	+	Strict	500	532.332	bacA	96.7	3002986	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	undecaprenyl pyrophosphate related proteins	ATGAGCGATATGCACTCGCTGCTGATAGCGGCAATTTTGGGTGTGGTCGAAGGATTGACGGAGTTTTTGCCGGTATCCAGCACGGGCCATATGATTATTGTGGGTCATCTGATGGGGTTTGAAGGCGATACGGCCAAGACATTCGAAGTGGTGATTCAACTTGGATCTATTCTGGCGGTCGTGGTGATGTTCTGGCGGCGGTTGTTTGGTCTCATCGGTATTCACTTTGGCCGCCCGCTACAGCGTGAAGGTGAAAGTAAAGGTCGATTAACGTTGATTCACATCCTGCTGGGCATGATTCCGGCGGTGGTGCTGGGGTTAGTCTTTCATGACACGATCAAGTCGCTATTTAACCCGATTAACGTGATGTACGCGCTGGTGGTAGGCGGTCTGTTGCTGATTGCCGCCGAGTGCCTGAAGCCGAAAGAACCGCGCGCGCCGGGGCTGGATGATATGACGTATCGTCAGGCGTTTATGATTGGCTGTTTCCAGTGTCTGGCGCTGTGGCCGGGCTTCTCGCGTTCCGGAGCGACCATTTCCGGTGGGATGCTGATGGGCGTCAGCCGTTACGCCGCCTCTGAGTTCTCGTTCTTACTGGCTGTGCCGATGATGATGGGCGCAACGGTTCTGGATCTCTACAAAAGTTGGTCATTCCTGACCGCAGCGGATATTCCAATGTTCGCGGTGGGCTTTGTGACGGCGTTTGTGGTGGCGCTGATCGCTATCAAGACCTTCCTGCAACTGATTAAGCGTATCTCGTTTATTCCGTTTGCGATTTACCGCTTTGTGGTGGCGGCTGCCGTTTACGTTGTCTTCTTCTGA	MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLMGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALIAIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF	MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF	100.00	gnl|BL_ORD_ID|1723|hsp_num:0	1820		
DAAGAT010000012.1_97 # 101111 # 102094 # -1 # ID=12_97;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.535	DAAGAT010000012.1_97	101111	102094	-	Strict	550	590.497	PmrF	87.74	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTTTGACGCCGCCCCCATAAAAAAAGTCTCGGTGGTTATTCCTGTCTATAACGAACAGGAAAGCCTGCCGGAATTGATAAGACGCACCACCACCGCCTGCGAGAGTCTGGGCAAAGCGTGGGAGATTTTATTGATAGATGATGGTAGCAGCGATAGCTCGGCGGAGCTGATGGTTAAGGCGTCCCAGGAGGCCGATAGCCATATCATCTCTATTTTACTCAACCGTAACTACGGTCAACATGCAGCGATTATGGCGGGGTTTAGCCATGTAAGCGGCGATCTCATCATTACGCTGGATGCCGATCTGCAAAACCCGCCGGAAGAGATCCCGCGCCTGGTGGCGAAAGCCGATGAAGGGTTCGATGTGGTAGGCACCGTGCGACAGAACCGACAGGACAGCCTGTTTCGCAAATCGGCGTCAAAAATCATTAATCTGCTGATCCAGCGCACAACGGGCAAAGCGATGGGCGATTACGGCTGCATGTTACGCGCCTATCGCCGCCCTATTATCGATACCATGTTGCGCTGCCATGAACGCAGCACCTTTATCCCTATTCTGGCCAATATTTTCGCTCGTCGGGCTACCGAAATCCCGGTGCATCACGCTGAACGTGAATTTGGCGACTCTAAATACAGTTTTATGCGTCTCATTAACCTGATGTATGACCTGGTGACCTGCCTGACGACGACGCCGCTGCGCCTGTTGAGTCTGCTGGGCAGCGTTATCGCCATCGGCGGGTTTAGCCTGTCGGTATTGCTTATTGTACTTCGCCTGGCGCTGGGACCGCAGTGGGCGGCGGAAGGCGTATTTATGCTCTTTGCCGTTCTGTTTACCTTCATCGGCGCGCAATTCATCGGTATGGGGCTGCTGGGCGAATACATCGGTCGCATTTATAACGATGTCCGCGCCCGCCCCCGCTATTTTGTTCAACAAGTTATCTACCCGGAAAGCACGTCGTTTACTGAGGAAAGTCACCAATGA	MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVKASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEGFDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHERSTFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLGSVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYNDVRARPRYFVQQVIYPESTSFTEESHQ	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	101.55	gnl|BL_ORD_ID|1980|hsp_num:0	2014		
DAAGAT010000013.1_45 # 46017 # 47249 # 1 # ID=13_45;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.549	DAAGAT010000013.1_45	46017	47249	+	Strict	700	726.087	Escherichia coli mdfA	87.93	3001328	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAGAATCGTTTACAATCAGGCGGCAGGCTGGGACGTCAGGCGCTACTTTTTCCTCTCTGTCTGGTGCTGTACGAATTTTCTACTTATATTGGCAACGACATGATCCAGCCGGGTATGCTGGCGGTGGTTGAGCAGTATCAGGCGGGCCTGGACTGGGTTCCGACGTCCATGACCGCTTATCTGGCGGGCGGTATGTTCTTACAGTGGCTGCTTGGCCCGTTGTCTGACCGGATTGGCCGTCGTCCCGTGATGCTGGCGGGCGTCGTGTGGTTTATTGTCACCTGCCTGGCGACGTTACTGGCGAAAAACATCGAACAATTTACCTTCCTGCGTTTTTTGCAAGGGATTAGCCTGTGTTTTATCGGCGCTGTAGGGTATGCCGCTATTCAGGAATCCTTTGAGGAAGCGGTGTGTATAAAAATTACCGCGCTGATGGCGAACGTGGCGTTAATCGCGCCGCTACTGGGACCACTGGTTGGGGCGGCATGGGTGCATGTTCTGCCGTGGGAGGGGATGTTTATTTTATTTGCCGCACTGGCCGCTATCGCCTTTTTCGGGCTACAGCGCGCAATGCCGGAGACCGCCACGCGGCGGGGCGAAACGCTGTCATTTAAGGCGCTTGGCCGGGATTATCGGCTGGTGATAAAAAACCGGCGGTTCGTCGCAGGGGCGTTAGCGCTGGGATTTGTCAGCCTGCCGCTGTTGGCCTGGATTGCGCAGTCGCCGATTATCATCATTAGCGGCGAACAGCTCAGCAGCTATGAATATGGTCTGCTGCAGGTGCCCGTTTTTGGCGCGCTCATTGCCGGTAATCTGGTGTTGGCGCGTTTAACCTCCCGACGTACGGTTCGCTCGCTGATCGTGATGGGCGGCTGGCCTATCGTCGCGGGGCTGATCATCGCCGCGGCGGCGACGGTGGTTTCATCCCATGCTTATTTATGGATGACGGCGGGATTAAGCGTATACGCTTTTGGCATTGGGCTGGCGAATGCCGGACTGGTGCGTCTGACGCTCTTTTCCAGCGATATGAGTAAAGGAACGGTCTCGGCGGCGATGGGAATGCTACAAATGCTGATTTTTACCGTTGGCATTGAAGTCAGTAAACACGCCTGGTTAAGTGGCGGCAATGGTCTATTTAGCCTGTTTAATCTGGCAAACGGTATTCTTTGGCTACTGCTGATGCTGGTCTTCTTAAAAGATAAGCGGACGGGCAATTTGCAAACAGTCTGA	MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAALAAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIAQSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLIIAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLIFTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV	MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG	100.00	gnl|BL_ORD_ID|2495|hsp_num:0	37		
DAAGAT010000013.1_120 # 134146 # 135894 # 1 # ID=13_120;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.517	DAAGAT010000013.1_120	134146	135894	+	Strict	1000	1160.59	msbA	96.39	3003950	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; acridine dye; rifamycin antibiotic; pleuromutilin antibiotic; nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCATAACGATAAAGATCTCTCTACGTGGCAGACCTTCCGCCGACTGTGGCCAACCATAGCGCCTTTTAAAGCAGGTCTGATCGTGGCGGGCATAGCGTTAATTCTCAACGCAGCCAGCGATACCTTCATGCTATCGCTCCTCAAGCCATTACTGGATGATGGTTTCGGTAAAACGGATCGCTCAGTGTTGCTGTGGATGCCGCTGGTGGTTATTGGGCTGATGATATTACGAGGCATCACTAGCTATATCTCCAGCTACTGTATTTCCTGGGTGTCAGGCAAGGTGGTAATGACCATGCGCCGTCGCCTGTTTGGCCATATGATGGGAATGCCCGTCGCCTTCTTTGATAAACAGTCTACCGGTACGCTGCTGTCGCGTATTACATACGATTCAGAACAGGTTGCCTCTTCTTCATCTGGCGCGCTGATTACCGTGGTGCGTGAAGGGGCATCGATCATCGGATTGTTTATCATGATGTTCTATTACAGCTGGCAGTTGTCGATCATCCTGGTTGTTTTAGCGCCGATTGTGTCGATTGCGATTCGCGTTGTCTCAAAGCGGTTCCGCAGCATCAGTAAAAATATGCAGAACACGATGGGACAAGTGACTACCAGCGCTGAACAAATGCTGAAAGGACACAAAGAGGTACTGATTTTTGGCGGTCAGGAAGTCGAAACTAAACGCTTTGATAAAGTCAGCAATAAGATGCGACTGCAAGGCATGAAAATGGTCTCTGCCTCGTCAATTTCCGATCCTATCATTCAGCTCATTGCCTCGCTGGCGCTGGCGTTTGTCCTCTATGCTGCGAGTTTCCCAAGCGTAATGGATAGCCTGACGGCAGGGACCATCACCGTGGTGTTCTCCTCCATGATCGCGCTGATGCGTCCATTAAAATCGCTGACAAACGTTAACGCGCAGTTCCAGCGTGGGATGGCGGCTTGTCAAACGTTGTTTGCGATTCTGGATAGCGAACAGGAGAAAGATGAAGGTAAACGTGTCATTGACCGCGCGACCGGCGATCTCGAATTCCGCAATGTGACGTTTACTTACCCGGGCCGTGAAGTGCCGGCATTGCGTAACATCAATTTGAAAATTCCTGCCGGGAAAACCGTGGCGCTGGTGGGGCGTTCCGGATCGGGTAAATCAACTATCGCCAGTCTGATCACCCGTTTCTACGATATTGATGAAGGGCACATCCTGATGGATGGTCACGATCTACGCGAATACACTCTGGCCTCTCTACGTAATCAGGTGGCGCTGGTTTCGCAAAACGTGCATCTGTTTAACGACACGGTCGCCAATAACATTGCTTATGCCCGGACGGAAGAATACAGCCGCGAGCAGATTGAAGAGGCGGCGCGCATGGCCTATGCCATGGACTTTATCAATAAGATGGATAATGGCCTGGATACCATCATCGGCGAAAACGGCGTACTGCTTTCCGGCGGTCAGCGCCAGCGTATCGCGATCGCCCGCGCCTTACTGCGCGACAGCCCGATTCTGATCCTTGATGAAGCTACGTCCGCGCTGGATACCGAATCTGAACGTGCGATTCAGGCAGCGTTGGATGAGCTGCAGAAAAACCGTACCTCTCTGGTGATTGCGCACCGTCTCTCCACCATCGAACAGGCGGATGAGATCGTTGTAGTCGAAGACGGTATTATCGTTGAGCGCGGCACTCATAGCGAGCTGCTGGCGCAACACGGCGTTTACGCCCAGCTACATAAGATGCAATTTGGCCAATGA	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGIALILNAASDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMILRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILVVLAPIVSIAIRVVSKRFRSISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGKRVIDRATGDLEFRNVTFTYPGREVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGHILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGIIVERGTHSELLAQHGVYAQLHKMQFGQ	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	100.00	gnl|BL_ORD_ID|2254|hsp_num:0	2423		
DAAGAT010000014.1_79 # 82276 # 83469 # 1 # ID=14_79;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.551	DAAGAT010000014.1_79	82276	83469	+	Strict	670	696.041	Escherichia coli acrA	91.69	3004043	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGACAAACAGGACCAGCAAGGCGGCCAGCAGATGCCAGAAGTTGGAGTTGTCACACTAAAAACGGAACCACTGCAAATCACAACTGAACTTCCGGGTCGTACCGTTGCTTACCGTATCGCCGAAGTTCGCCCGCAGGTAAGCGGCATTATCCTGAAGCGTAATTTCGTTGAGGGAAGTGATATCGAAGCGGGAGTCTCTCTCTATCAGATTGATCCTGCGACCTACCAGGCGACTTACGACAGCGCTAAGGGCGATCTGGCAAAAGCGCAGGCCGCCGCGAATATTGCTGAACTGACGGTGAAGCGTTATCAAAAGCTGCTGGGTACGCAGTACATCAGTAAGCAGGAATACGATCAGGCGCTGGCTGACGCACAACAAGCGACTGCCGCTGTTGTCGCAGCAAAAGCCGCCGTTGAAACCGCACGTATCAACCTGGCGTATACCAAAGTCACCTCACCGATTAGCGGTCGTATTGGTAAGTCGTCCGTAACGGAAGGCGCGCTGGTACAGAACGGTCAGGCGTCGGCGCTGGCGACAGTGCAGCAGCTGGACCCTATTTATGTCGATGTGACCCAGTCCAGCAATGACTTCCTGCGCCTGAAGCAGGAGCTGGCAAATGGTTCGCTGAAACAGGAAAACGGCAAAGCGAAGGTCGACCTGGTGACCAGCGACGGTATCAAATTCCCGCAGTCCGGTACGCTTGAATTCTCCGATGTGACCGTTGACCAAACCACCGGGTCTATTACTTTGCGCGCCATCTTCCCTAACCCGGATCACACCTTATTGCCAGGAATGTTCGTTCGCGCACGTCTGCAGGAAGGGACAAAACCGACGGCATTACTGGTTCCACAACAGGGCGTTACCCGTACTCCACGCGGCGATGCCACGGTGCTGGTGGTTGGCGCTGATAACAAAGTGGAAACCCGCCAAATCGTCGCAAGCCAGGCGATCGGCGATAAGTGGCTGGTGACTGACGGGTTGAAAGCGGGCGACCGCGTAGTCGTCAGCGGGCTGCAAAAAGTACGTCCTGGCGCACAGGTTAAAGTGCAGGAAATTACCGCGGATAACAAACAGCAAGCCGCAAGCGGTGATCAACCTGCTCAGCCCAGGTCTTAA	MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRTVAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAELTVKRYQKLLGTQYISKQEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPISGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENGKAKVDLVTSDGIKFPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLQEGTKPTALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVASQAIGDKWLVTDGLKAGDRVVVSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	100.00	gnl|BL_ORD_ID|2391|hsp_num:0	2661		
DAAGAT010000014.1_80 # 83492 # 86641 # 1 # ID=14_80;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.545	DAAGAT010000014.1_80	83492	86641	+	Strict	1900	2001.87	acrB	94.57	3000216	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCTAATTTCTTTATCGATCGCCCTATATTTGCGTGGGTGATCGCCATCATCATCATGTTGGCAGGGGGGCTCGCGATCCTCAAATTGCCGGTAGCGCAATATCCGACGATTGCGCCACCAGCAGTGACGATCTCCGCAACCTACCCTGGCGCTGATGCGAAAACGGTACAGGATACCGTCACGCAGGTTATCGAACAGAATATGAACGGTATCGATAACCTGATGTATATGTCCTCCAACAGTGACTCCACGGGGACCGTGCAGATCACGCTGACCTTTGAATCCGGCACCGATGCGGATATCGCGCAGGTTCAGGTTCAGAACAAGTTGCAACTGGCAATGCCGTTACTTCCCCAGGAAGTACAGCAACAGGGCGTGAGCGTTGAGAAGTCCTCAAGTAGCTTCCTGATGGTAGTGGGCGTCATTAACACCGACGGCACCATGACCCAGGAGGATATTTCGGATTACGTTGCCGCCAATATGAAAGATCCGATCAGCCGTACCTCTGGGGTGGGCGACGTCCAGCTGTTTGGTTCGCAGTATGCGATGCGTATCTGGATGAATCCGACAGAGCTGACCAAATACCAACTGACGCCGGTCGACGTGATTAACGCGATCAAAGCGCAGAACGCCCAGGTCGCGGCTGGTCAGCTCGGTGGTACGCCGCCGGTAAAAGGCCAGCAGCTTAACGCATCGATTATTGCCCAAACGCGTCTGACCTCAACGGATGAGTTTGGCAAAATCCTGCTGAAGGTGAATCAGGATGGCTCTCAGGTTCGTCTGCGGGATGTAGCGAAAATTGAGCTTGGCGGCGAGAACTACGACGTCATCGCGAAATTTAACGGTCAGCCAGCGTCAGGTCTTGGCATCAAACTGGCTACCGGCGCCAACGCGCTGGATACCGCTACCGCTATTCGCGCCGAACTGAAAAAAATGGAACCGTTCTTCCCGCCAGGGATGAAAATCGTCTACCCGTATGACACCACGCCGTTCGTGAAGATCTCTATTCATGAAGTGGTAAAAACGCTGGTCGAAGCGATTATCCTCGTGTTCCTGGTGATGTACCTGTTCCTGCAGAACTTCCGCGCGACGTTGATTCCGACTATTGCGGTTCCGGTGGTGTTGTTGGGAACCTTTGCCGTGCTTGCGGCATTCGGTTTCTCGATAAACACGCTGACGATGTTCGGGATGGTGCTCGCCATCGGCTTGCTGGTGGATGACGCCATCGTGGTGGTCGAGAACGTCGAACGTGTTATGACGGAAGAAGGCCTTCCGCCGAAGGAAGCGACGCGCAAATCCATGGGCCAGATTCAGGGCGCATTGGTGGGTATCGCGATGGTACTGTCGGCGGTATTTATTCCGATGGCCTTCTTTGGCGGCTCAACCGGGGCAATTTATCGTCAGTTCTCTATCACCATCGTATCGGCGATGGCGCTGTCGGTGCTGGTCGCGCTGATCCTGACGCCTGCGCTGTGCGCGACGATGCTCAAACCCGTCGCCAAAGGCGATCATGGCGAAGGGAAAAAAGGCTTTTTCGGCTGGTTTAACCGCCTGTTCGATAAGAGCACGCATCACTACACCGATAGCGTAGGCAATATTCTGCGCAGCACCGGGCGTTATCTGCTGCTCTATCTCATTATCGTCGTCGGTATGGCTTATCTGTTCGTTCGTCTGCCAAGCTCTTTCTTGCCGGATGAAGACCAGGGCGTATTCCTGACAATGGTCCAGCTCCCCGCCGGCGCGACGCAAGAGCGCACGCAAAAAGTGCTGGATGAGGTCACGGATTACTATCTGAACAAAGAGAAAGCCAACGTTGAATCGGTATTCGCCGTCAACGGCTTCGGTTTTGCAGGGCGCGGTCAGAATACCGGTATTGCATTCGTGTCGTTGAAAGACTGGGCCGATCGTCCAGGCGAAAAAAACAAGGTTGAAGCGATTACCCAGCGGGCAACCGCAGCGTTTTCACAAATTAAAGATGCGATGGTCTTCGCCTTTAACCTGCCGGCGATTGTTGAACTGGGCACCGCAACCGGGTTTGACTTCGAGTTGATTGACCAGGCGGGACTTGGTCATGAAAAACTCACCCAGGCGCGTAATCAGTTGTTCGGCGAGGTGGCGAAATATCCTGATCTGCTGGTCGGCGTTCGACCTAACGGTCTGGAAGATACGCCGCAGTTTAAAATCGATATCGACCAGGAAAAAGCTCAGGCGCTGGGCGTGTCTATTAGCGACATTAATACCACGCTGGGCGCAGCATGGGGCGGCAGCTATGTAAACGACTTTATCGATCGCGGTCGTGTGAAGAAAGTTTACGTGATGTCCGAAGCGAAATACCGCATGTTGCCGGATGATATTAACGACTGGTACGTTCGTGGTAGCGATGGTCAGATGGTGCCGTTCTCCGCATTCTCCTCTTCCCGCTGGGAATATGGTTCGCCGCGTCTGGAACGCTATAACGGTCTGCCTTCGATGGAAATTCTGGGTCAGGCGGCGCCAGGCAAGAGTACTGGTGAAGCGATGGCGATGATGGAGGAACTGGCCAGCAAGCTGCCGTCAGGCATTGGATATGACTGGACCGGGATGTCCTACCAGGAGCGGTTGTCCGGCAACCAGGCCCCTGCCCTGTATGCTATCTCGCTGATCGTCGTCTTCCTGTGTCTGGCGGCATTGTATGAGAGCTGGTCTATCCCGTTCTCCGTAATGCTGGTTGTTCCGCTTGGGGTTATCGGCGCGCTGCTGGCTGCGACCTTCCGCGGACTGACTAACGACGTTTACTTCCAGGTGGGCCTGCTCACAACCATTGGGTTGTCGGCGAAGAACGCGATACTTATCGTCGAATTCGCCAAAGACTTAATGGATAAAGAAGGGAAAGGTCTGGTAGAAGCGACGCTGGAGGCCGTCCGGATGCGTTTGCGTCCGATTTTGATGACCTCGTTAGCGTTCATGCTGGGGGTTATGCCGCTGGTTATCAGTTCCGGCGCGGGTTCCGGCGCGCAGAATGCGGTAGGTACTGGCGTACTGGGCGGGATGGTAACGGCAACCGTACTGGCTATTTTCTTCGTACCGGTCTTCTTCGTGGTGGTACGCCGCCGCTTTAGCCGTAAAAGCGAAGATATTGAGCATAGTCATTCGACAGAACATCGCTGA	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANALDTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMTEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGRYLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYYLNKEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNGLEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLVEATLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIFFVPVFFVVVRRRFSRKSEDIEHSHSTEHR	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	100.00	gnl|BL_ORD_ID|1037|hsp_num:0	1104		
DAAGAT010000016.1_55 # 60888 # 62261 # 1 # ID=16_55;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.574	DAAGAT010000016.1_55	60888	62261	+	Strict	890	908.286	cpxA	96.94	3000830	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATAGGAAGTTTAACCGCGCGCATCTTCGCCATCTTCTGGTTGACGCTGGCGCTGGTGCTAATGCTGGTACTGATGTTGCCCAAGCTCGATTCACGCCAGATGACCGAGCTGCTGGACAGCGAACAGCGCCAGGGATTGATGATAGAGCAACATGTAGAAGCTGAACTTGCGAACGATCCGCCCAACGACCTGATGTGGTGGCGTCGCCTGTTCCGCGCGATCGATAAGTGGGCGCCGCCTGGACAGCGGTTATTACTGGTGACCTCTGAAGGACGCGTGATCGGTGCTGAACGCAGCGAAATGCAGATCATTCGTAACTTCATTGGTCAGGCGGATAACGCCGATCATCCGCAGAAGAAAAAATATGGCCGCGTAGAGATGGTGGGGCCGTTCTCCGTTCGCGACGGAGAGGATAATTACCAGCTTTACCTGATTCGACCGGCCAGCAGTTCGCAATCCGATTTTATTAATCTGCTGTTTGACCGCCCGCTTCTGTTGCTCATTGTCACGATGCTGGTCAGTTCGCCGCTCTTGCTATGGCTGGCATGGAGTCTGGCGAAACCGGCGCGTAAGTTGAAAAACGCGGCTGATGAAGTGGCGCAAGGCAACCTGCGTCAGCATCCGGAGCTGGAGGCGGGTCCGCAGGAGTTCCTCGCCGCTGGCGCCAGTTTTAACCAGATGGTGACGGCGCTGGAACGGATGATGACCTCGCAGCAGCGTTTGCTGTCAGACATCTCCCATGAGCTGCGAACGCCCCTTACGCGCCTGCAACTGGGTACCGCGCTGCTGCGTCGTCGTGGCGGCGAAAGCAAAGAGCTGGAGCGTATTGAAACCGAAGCGCAGCGTCTGGACAGCATGATCAATGACCTGCTGGTGATGTCGCGTAACCAACAGAAAAATGCGCTGGTCAGCGAAACGATGAAAGCCAATCAGCTATGGGGCGAAGTGCTGGATAACGCCGCCTTTGAAGCCGAACAGATGGGCAAGTCGTTAACGGTAAATTATCCGCCGGGGCCGTGGCCGCTCTATGGCAACCCAAACGCGCTGGAAAGCGCGCTGGAAAATATTGTTCGTAATGCGCTGCGCTATTCACATACGAAGATTGAAGTCGGCTTCTCGGTGGATAAAGACGGTATTACGATCACGGTCGATGACGACGGGCCGGGCGTCAGCCCTGAAGACCGTGAGCAGATCTTCCGTCCGTTCTATCGCACTGATGAGGCGCGCGACCGCGAGTCTGGCGGCACCGGGCTGGGGCTGGCGATTGTCGAAAGCGCCATGCAGCAGCACCGCGGCTGGGTGAAGGCTGACGATAGCCCGCTCGGCGGGTTGCGGCTCACGCTGTGGCTACCGCTGTACAAGCGAACCTAA	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTSEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVEMVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSSPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRGGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETMKANQLWGEVLDNAAFEAEQMGKSLTVNYPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFSVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVESAMQQHRGWVKADDSPLGGLRLTLWLPLYKRT	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	100.00	gnl|BL_ORD_ID|136|hsp_num:0	152		
DAAGAT010000029.1_22 # 16662 # 17294 # 1 # ID=29_22;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.504	DAAGAT010000029.1_22	16662	17294	+	Strict	400	432.95	CRP	99.05	3000518	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCGTCAAAGAGCACGCTGATTCACCAGGGTGAAAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCAGTGCTGATCAAAGATGAAGAAGGGAAAGAAATGATCCTTTCTTATCTGAATCAGGGTGATTTTATTGGTGAACTGGGCCTGTTTGAAGAAGGCCAGGAACGCAGCGCCTGGGTACGTGCGAAAACCGCATGTGAGGTCGCTGAAATTTCCTACAAAAAATTTCGCCAATTAATCCAGGTCAACCCGGATATTCTGATGCGCCTCTCTTCCCAGATGGCTCGTCGCTTACAAGTCACCTCTGAAAAAGTAGGTAACCTCGCCTTCCTTGACGTCACCGGGCGTATCGCTCAGACGCTGCTGAATCTGGCGAAACAGCCCGATGCCATGACGCACCCGGATGGGATGCAGATCAAAATCACCCGTCAGGAAATCGGCCAGATCGTCGGCTGCTCCCGCGAAACCGTTGGTCGTATTTTGAAAATGCTGGAAGATCAAAACCTGATCTCCGCGCATGGCAAGACCATCGTCGTCTACGGCACCCGTTAA	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	100.00	gnl|BL_ORD_ID|820|hsp_num:0	869		
DAAGAT010000036.1_10 # 7292 # 7573 # -1 # ID=36_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.489	DAAGAT010000036.1_10 	7292	7573	-	Strict	1650	23.0978	Brucella suis mprF	100.0	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAAAATCAGCCAGCTGGAATCCGGGATGCAGGTTTGGTCTGTAACCCGTACCAAAATGGGAAATACCACCATTTCAACGGTCATTGTCCACCCCGTTGTCATTATTGAAATTCATGATAACCATGTGATTGCTCGCTGGAACGGCAATGCACCACGTCGGTTTGGAGAAACGGCTATCAGGGGCTGGAAGAAGGAGAAGCCACTGCTTGTCCGTGAGCCTTTCGGAAATGTTCGTCTGGCCACCCGGGCTGAAAAAACCGCTATGCAGGAAAAAGAGTAA	MKISQLESGMQVWSVTRTKMGNTTISTVIVHPVVIIEIHDNHVIARWNGNAPRRFGETAIRGWKKEKPLLVREPFGNVRLATRAEKTAMQEKE	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	10.57	gnl|BL_ORD_ID|2116|hsp_num:0	2281	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000041.1_1 # 222 # 881 # 1 # ID=41_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.447	DAAGAT010000041.1_1	222	881	+	Perfect	350	465.692	Shigella flexneri chloramphenicol acetyltransferase	100.0	3004459	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	100.00	gnl|BL_ORD_ID|2581|hsp_num:0	2898		
DAAGAT010000042.1_1 # 104 # 940 # -1 # ID=42_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.559	DAAGAT010000042.1_1	104	940	-	Strict	500	568.155	APH(6)-Id	99.64	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	100.00	gnl|BL_ORD_ID|973|hsp_num:0	1031		
DAAGAT010000042.1_2 # 940 # 1743 # -1 # ID=42_2;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.562	DAAGAT010000042.1_2	940	1743	-	Strict	500	541.191	APH(3'')-Ib	99.63	3002639	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTGATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	100.00	gnl|BL_ORD_ID|1732|hsp_num:0	1830		
DAAGAT010000045.1_1 # 132 # 1751 # 1 # ID=45_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.449	DAAGAT010000045.1_1	132	1751	+	Perfect	1000	1125.15	MCR-9.1	100.0	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGCCTGTACTTTTCAGGGTGAAAGTTATTCCGCTGGTTTTACTTCTGGCAATGATCTTTGCGTTTTTACTTAACTGGCCAATATTGCTGCATTTTTACGAGATTTTGTCGCATTTAGAGCATGTCAAAATTGGTTTTGTCATTTCTATTCCCTTTGTTCTGGTTGCGGCGCTTAACGTTGTTTTTATGCCTTTCTCAGTTCGTTTTCTGCTGAAACCTTTCTTTGCTTTACTGTTTATCACTGGCTCACTGGTCAGTTATTCGACACTAAAATATAAAGTAATGTTTGATCAAACGATGATTCAAAACATTATTGAAACTAACCCCCAGGAAGCGCATTCCTATCTTAATGGCTCAATTATTATATGGTTCGTCTTTACCGGTATCCTTCCTGCCATCCTCCTTTTTTCAATAAAAATTCAATATCCTGAAAAATGGTATAAAGGCATTGCTTACCGTTTGCTCTCCGTGCTGGCATCGTTGAGTTTGATTGCAGGTGTTGCCGCACTTTATTATCAGGATTATGCCTCTGTCGGCCGCAATAACTCGACATTGAATAAAGAGATCATCCCGGCGAACTACGCTTACAGCACTTTCCAGTATGTTAAGGATACGTACTTTACGACTAAAGTGCCTTTCCAGACGCTGGGGAATGATGCTAAACGCGTCGTCGCTCACGAAAAACCCACGCTGATGTTCCTGGTGATTGGCGAAACGGCACGCAGCCAGAATTTCTCGATGAACGGTTATTCGCGTGATACCAATGCCTTTACCAGCAAATCCGGCGGCGTTATTTCGTTTAAAAATATGCATTCCTGCGGTACCGCTACCGCAATATCCGTTCCGTGCATGTTCTCGAATATGAATCGCACCGAGTACGACAGTAAAAAAGCATCTAACAGTGAAAATTTCCTCGACATCGTGCAGAAAACCGGTGTCTCGCTGTTATGGAAAGAGAACGATGGCGGTTGTAAAGGCGTATGTAGCCGCATCCCGACTGTCGAAATTAAGCCTAGTGATAACCCGAAACTGTGCGATGGCAAAACGTGCCATGACGAGGTGATGCTGGAAAACCTTGATGATGAAATCGCCAAAATGCCAGGTGATAAGCTTGTCGCCTTCCATATCATTGGCAGCCATGGACCGACTTATTACCTGCGTTATCCGGCTGAGCATCGCCACTTCATGCCCGAATGTGCACGTAGCGATATCGAAAACTGTACTCAGGAACAATTGGTCAACACCTACGACAACACCCTTCGTTATACAGACTATGTATTAGCTGAGATGATTGAAAAGCTAAAAAATTACAGCGATCAGTACAACACCGTGCTGCTTTATGTGTCCGATCATGGTGAATCATTGGGCGAAAGCGGGCTATATCTGCACGGCACGCCGTACAAACTGGCACCGGATCAGCAGACGCATATTCCGATGCAGGTCTGGATGTCACCGGGCTTTATCGCCGGGAAACACATCAACATGTCTTGCCTTGAAAATAATGCGGCGAAAAAATCATATTCCCACGACAACCTGTTCTCATCGATTTTGGGGCTGTGGGACGTAAGCACCAGCGTCTATAATCCTGACCGCGATTTGTTCCGCGAATGCCGTGGCTAA	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	100.00	gnl|BL_ORD_ID|2311|hsp_num:0	3383		
DAAGAT010000053.1_1 # 3 # 380 # -1 # ID=53_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.532	DAAGAT010000053.1_1 	3	380	-	Strict	450	253.447	ANT(3'')-IIa	100.0	3004089	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACG	MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT	MVTAQWRFSWLLVMTCFFGVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	39.01	gnl|BL_ORD_ID|2455|hsp_num:0	2752	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000053.1_2 # 450 # 968 # -1 # ID=53_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.541	DAAGAT010000053.1_2	450	1005	-	Perfect	275	357.066	AAC(6')-Ib4	100.0	3002577	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTCACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCACTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	93.48	gnl|BL_ORD_ID|947|hsp_num:0	1002	True	possible complete gene, missing n-terminus
DAAGAT010000053.1_3 # 1112 # 1912 # -1 # ID=53_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.558	DAAGAT010000053.1_3	1112	1912	-	Perfect	400	536.569	VIM-1	100.0	3002271	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGTTAAAAGTTATTAGTAGTTTATTGGTCTACATGACCGCGTCTGTCATGGCTGTCGCAAGTCCGTTAGCCCATTCCGGGGAGCCGAGTGGTGAGTATCCGACAGTCAACGAAATTCCGGTCGGAGAGGTCCGACTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCGGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAAAAGCAAATTGGACTTCCCGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGCAGAGGGGAACGAGATTCCCACGCATTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAGCTCTTCTATCCTGGTGCTGCGCATTCGACCGACAATCTGGTTGTATACGTCCCGTCAGCGAACGTGCTATACGGTGGTTGTGCCGTTCATGAGTTGTCAAGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCGTTGAGCGGATTCAAAAACACTACCCGGAAGCAGAGGTCGTCATTCCCGGGCACGGTCTACCGGGCGGTCTAGACTTGCTCCAGCACACAGCGAACGTTGTCAAAGCACACAAAAATCGCTCAGTCGCCGAGTAG	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	100.00	gnl|BL_ORD_ID|1141|hsp_num:0	1211		
DAAGAT010000055.1_1 # 3 # 368 # -1 # ID=55_1;partial=10;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.538	DAAGAT010000055.1_1 	3	368	-	Strict	450	244.202	ANT(3'')-IIa	99.18	3004089	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	GTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACGTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAGTTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACG	MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT	MVTAQWRFSWLLVMTCFFGVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	37.77	gnl|BL_ORD_ID|2455|hsp_num:0	2752	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000055.1_2 # 465 # 1685 # -1 # ID=55_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.499	DAAGAT010000055.1_2	465	1685	-	Strict	700	775.007	EreA2	92.4	3002826	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGACATGGAGAACGACCAGAACACTTTTACAGCCTCAAAAGCTGGACTTCAATGAGTTTGAGATTCTTACTTCCGTAATTGAGGGCGCCCGAATTGTCGGCATTGGCGAGGGCGCTCATTTTGTCGCGGAGTTTTCACTGGCTAGAGCTAGTCTTATCCGCTATTTGGTCGAAAGGCATGAGTTTAATGCGATTGGTTTGGAATGTGGGGCGATTCAGGCATCCCGGTTATCTGAATGGCTCAACTCAACAGCCGGTGCTCATGAACTTGAGCGATTTTCGGATACCCTGACCTTTTCTGTGTATGGCTCAGTGCTGATCTGGCTGAAATCATATCTCCGCGAATCAGGAAGAAAACTGCAGTTAGTCGGAATCGACTTACCCAACACCCTGAACCCAAGGGACGACCTAGCGCAATTGGCCGAAATTATCCAGCTCATCGATCACCTCATGAAACCGCACGTTGATATGTTGACTCACTTGTTGGCGTCCATTGATGGCCAGTCGGCGGTTATTTCATCGGCAAAATGGGGGGAGCTAGAAACGGCTCGGCAGGAGAAAGCTATCTCAGGGGTAACCAGATTGAAGCTCCGCTTGGCGTCGCTTGCCCCCGTCCTGAAAAAACACGTCAACAGCGATTTGTTCCGAAAAGCCTCTGATCGAATAGAGTCGATAGAGTATACGTTGGAAACCTTGCGTATAATGAAAACTTTCTTCGATGGTACCTCTCTTGAGGGAGATACTTCCGTACGTGACTCGTATATGGCGGGCGTAGTAGATGGAACGGTTCGAGCGAATCCGGATGTGAAGATAATTCTGCTGGCGCACAACAATCATTTACAAAAAACTCCAGTCTCCTTTTCAGGCGAGCTTACGGCTGTTCCCATGGGGCAGCACCTCGCAGAGAGGGTGAATTACCGTGCGATTGCATTCACCCATCTTGGACCCACCGTGCCGGAAATGCATTTCCCATCGCCAAAAAGTCCTCTTGGATTCTCTGTTGTGACCACGCCTGCCGATGCAATCCGTGAGGATAGTATGGAACAGTATGTCATCGACGCCTGTGGTACGGAGAATTCATGTCTGACATTGACAGATGCCCCCATGGAAGCAAAGCGAATGCGGTCTCAAAGCGCCTCTGTAGAAACGAAATTGAGCGAGGCATTTGATGCCATCGTCTGTGTTACAAGCGCCGGCAAGGACAGCCTGGTTGCCCTATAG	MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERHEFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGELETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFDGTSLEGDTSVRDSYMAGVVDGTVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHLAERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENSCLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL	MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERHDFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGELETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHLAEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKEDSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL	99.51	gnl|BL_ORD_ID|1431|hsp_num:0	1518		
DAAGAT010000059.1_1 # 3 # 1244 # 1 # ID=59_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.474	DAAGAT010000059.1_1	84	1244	+	Perfect	700	793.882	ACC-1	100.0	3001815	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	ATGCAGAACACATTGAAGCTGTTATCCGTGATTACCTGTCTGGCAGCAACTGTCCAAGGTGCTCTGGCTGCTAATATCGATGAGAGCAAAATTAAAGACACCGTTGATGACCTGATCCAGCCGCTGATGCAGAAGAATAATATTCCCGGTATGTCGGTCGCAGTGACCGTCAACGGTAAAAACTACATTTATAACTATGGGTTAGCGGCAAAACAGCCTCAGCAGCCGGTTACGGAAAATACGTTATTTGAAGTGGGTTCGCTGAGTAAAACGTTTGCTGCCACCTTGGCGTCCTATGCGCAGGTGAGCGGTAAGCTGTCTTTGGATCAAAGCGTTAGCCATTACGTTCCAGAGTTGCGTGGCAGCAGCTTTGACCACGTTAGCGTACTCAATGTGGGCACGCATACCTCAGGCCTACAGCTATTTATGCCGGAAGATATTAAAAATACCACACAGCTGATGGCTTATCTAAAAGCATGGAAACCTGCCGATGCGGCTGGAACCCATCGCGTTTATTCCAATATCGGTACTGGTTTGCTAGGGATGATTGCGGCGAAAAGTCTGGGTGTGAGCTATGAAGATGCGATTGAGAAAACCCTCCTTCCTCAGTTAGGCATGCATCACAGCTACTTGAAGGTTCCGGCTGACCAGATGGAAAACTATGCGTGGGGCTACAACAAGAAAGATGAGCCAGTGCACGTGAATATGGAGATTTTGGGTAACGAAGCTTATGGTATCAAAACCACCTCCAGCGACTTGTTACGCTACGTGCAAGCCAATATGGGGCAGTTAAAGCTTGATGCTAATGCCAAGATGCAACAGGCTCTGACAGCCACCCACACCGGCTATTTCAAATCGGGTGAGATTACTCAGGATCTGATGTGGGAGCAGCTGCCATATCCGGTTTCTCTGCCGAATTTGCTCACCGGTAACGATATGGCGATGACGAAAAGCGTGGCTACGCCGATTGTTCCGCCGTTACCGCCACAGGAAAATGTGTGGATTAATAAGACCGGATCAACTAACGGCTTCGGTGCCTATATTGCGTTTGTTCCTGCTAAGAAGATGGGGATCGTGATGCTGGCTAACAAAAACTACTCAATCGATCAGCGAGTGACGGTGGCGTATAAAATCCTGAGCTCATTGGAAGGGAATAAGTAG	MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	106.99	gnl|BL_ORD_ID|1572|hsp_num:0	1663	True	possible complete gene, reference contained within open reading frame
DAAGAT010000060.1_3 # 715 # 1395 # -1 # ID=60_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.609	DAAGAT010000060.1_3 	715	1395	-	Strict	500	450.669	sul1	100.0	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	AGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	RPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	81.00	gnl|BL_ORD_ID|1005|hsp_num:0	1070	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000076.1_1 # 1 # 375 # 1 # ID=76_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.539	DAAGAT010000076.1_1 	1	375	+	Strict	450	255.758	aadA22	99.2	3002619	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	CTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAGAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAG	LTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITK	MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVIGK	47.53	gnl|BL_ORD_ID|1309|hsp_num:0	1392	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000079.1_3 # 3441 # 4244 # 1 # ID=79_3;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.562	DAAGAT010000079.1_3	3441	4244	+	Strict	500	541.191	APH(3'')-Ib	99.63	3002639	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTGATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	100.00	gnl|BL_ORD_ID|1732|hsp_num:0	1830		
DAAGAT010000079.1_4 # 4244 # 5080 # 1 # ID=79_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.559	DAAGAT010000079.1_4	4244	5080	+	Strict	500	568.155	APH(6)-Id	99.64	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	100.00	gnl|BL_ORD_ID|973|hsp_num:0	1031		
DAAGAT010000080.1_1 # 133 # 1752 # 1 # ID=80_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.449	DAAGAT010000080.1_1	133	1752	+	Perfect	1000	1125.15	MCR-9.1	100.0	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGCCTGTACTTTTCAGGGTGAAAGTTATTCCGCTGGTTTTACTTCTGGCAATGATCTTTGCGTTTTTACTTAACTGGCCAATATTGCTGCATTTTTACGAGATTTTGTCGCATTTAGAGCATGTCAAAATTGGTTTTGTCATTTCTATTCCCTTTGTTCTGGTTGCGGCGCTTAACGTTGTTTTTATGCCTTTCTCAGTTCGTTTTCTGCTGAAACCTTTCTTTGCTTTACTGTTTATCACTGGCTCACTGGTCAGTTATTCGACACTAAAATATAAAGTAATGTTTGATCAAACGATGATTCAAAACATTATTGAAACTAACCCCCAGGAAGCGCATTCCTATCTTAATGGCTCAATTATTATATGGTTCGTCTTTACCGGTATCCTTCCTGCCATCCTCCTTTTTTCAATAAAAATTCAATATCCTGAAAAATGGTATAAAGGCATTGCTTACCGTTTGCTCTCCGTGCTGGCATCGTTGAGTTTGATTGCAGGTGTTGCCGCACTTTATTATCAGGATTATGCCTCTGTCGGCCGCAATAACTCGACATTGAATAAAGAGATCATCCCGGCGAACTACGCTTACAGCACTTTCCAGTATGTTAAGGATACGTACTTTACGACTAAAGTGCCTTTCCAGACGCTGGGGAATGATGCTAAACGCGTCGTCGCTCACGAAAAACCCACGCTGATGTTCCTGGTGATTGGCGAAACGGCACGCAGCCAGAATTTCTCGATGAACGGTTATTCGCGTGATACCAATGCCTTTACCAGCAAATCCGGCGGCGTTATTTCGTTTAAAAATATGCATTCCTGCGGTACCGCTACCGCAATATCCGTTCCGTGCATGTTCTCGAATATGAATCGCACCGAGTACGACAGTAAAAAAGCATCTAACAGTGAAAATTTCCTCGACATCGTGCAGAAAACCGGTGTCTCGCTGTTATGGAAAGAGAACGATGGCGGTTGTAAAGGCGTATGTAGCCGCATCCCGACTGTCGAAATTAAGCCTAGTGATAACCCGAAACTGTGCGATGGCAAAACGTGCCATGACGAGGTGATGCTGGAAAACCTTGATGATGAAATCGCCAAAATGCCAGGTGATAAGCTTGTCGCCTTCCATATCATTGGCAGCCATGGACCGACTTATTACCTGCGTTATCCGGCTGAGCATCGCCACTTCATGCCCGAATGTGCACGTAGCGATATCGAAAACTGTACTCAGGAACAATTGGTCAACACCTACGACAACACCCTTCGTTATACAGACTATGTATTAGCTGAGATGATTGAAAAGCTAAAAAATTACAGCGATCAGTACAACACCGTGCTGCTTTATGTGTCCGATCATGGTGAATCATTGGGCGAAAGCGGGCTATATCTGCACGGCACGCCGTACAAACTGGCACCGGATCAGCAGACGCATATTCCGATGCAGGTCTGGATGTCACCGGGCTTTATCGCCGGGAAACACATCAACATGTCTTGCCTTGAAAATAATGCGGCGAAAAAATCATATTCCCACGACAACCTGTTCTCATCGATTTTGGGGCTGTGGGACGTAAGCACCAGCGTCTATAATCCTGACCGCGATTTGTTCCGCGAATGCCGTGGCTAA	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	100.00	gnl|BL_ORD_ID|2311|hsp_num:0	3383		
DAAGAT010000081.1_2 # 452 # 1291 # 1 # ID=81_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.617	DAAGAT010000081.1_2	452	1291	+	Perfect	500	553.132	sul1	100.0	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	100.00	gnl|BL_ORD_ID|1005|hsp_num:0	1070		
DAAGAT010000082.1_2 # 452 # 1291 # 1 # ID=82_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.615	DAAGAT010000082.1_2	452	1291	+	Strict	500	551.592	sul1	99.64	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGATCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGSAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	100.00	gnl|BL_ORD_ID|1005|hsp_num:0	1070		
DAAGAT010000083.1_1 # 1 # 852 # 1 # ID=83_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.616	DAAGAT010000083.1_1	1	852	+	Strict	500	551.592	sul1	100.0	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGTTACGCAGCAGGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	MLRSRVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	101.43	gnl|BL_ORD_ID|1005|hsp_num:0	1070		
DAAGAT010000084.1_1 # 1 # 825 # 1 # ID=84_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.560	DAAGAT010000084.1_1	25	825	+	Perfect	400	536.569	VIM-1	100.0	3002271	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGTTAAAAGTTATTAGTAGTTTATTGGTCTACATGACCGCGTCTGTCATGGCTGTCGCAAGTCCGTTAGCCCATTCCGGGGAGCCGAGTGGTGAGTATCCGACAGTCAACGAAATTCCGGTCGGAGAGGTCCGACTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCGGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAAAAGCAAATTGGACTTCCCGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGCAGAGGGGAACGAGATTCCCACGCATTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAGCTCTTCTATCCTGGTGCTGCGCATTCGACCGACAATCTGGTTGTATACGTCCCGTCAGCGAACGTGCTATACGGTGGTTGTGCCGTTCATGAGTTGTCAAGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCGTTGAGCGGATTCAAAAACACTACCCGGAAGCAGAGGTCGTCATTCCCGGGCACGGTCTACCGGGCGGTCTAGACTTGCTCCAGCACACAGCGAACGTTGTCAAAGCACACAAAAATCGCTCAGTCGCCGAGTAG	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	103.01	gnl|BL_ORD_ID|1141|hsp_num:0	1211	True	possible complete gene, reference contained within open reading frame
DAAGAT010000084.1_2 # 861 # 1487 # 1 # ID=84_2;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.547	DAAGAT010000084.1_2	861	1487	+	Strict	275	400.593	AAC(6')-Ib8	94.69	3002579	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	TTGCTACGCAGGCTGCGCCTACTCCGCAAAAGCCCCTCAACTCAGGCGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTCACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCACTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA	MLRRLRLLRKSPSTQALGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	MSLKPGPKRIAESTGQPDQRQRDNKKTPGNTDKLGITKYSIVTNSTDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	92.44	gnl|BL_ORD_ID|1953|hsp_num:0	2071		
DAAGAT010000085.1_1 # 43 # 702 # 1 # ID=85_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.447	DAAGAT010000085.1_1	43	702	+	Perfect	350	465.692	Shigella flexneri chloramphenicol acetyltransferase	100.0	3004459	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	100.00	gnl|BL_ORD_ID|2581|hsp_num:0	2898		
DAAGAT010000086.1_1 # 73 # 1245 # 1 # ID=86_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.480	DAAGAT010000086.1_1	85	1245	+	Perfect	700	793.497	ACC-1	100.0	3001815	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	ATGCAGAACACATTGAAGCTGTTATCCGTGATTACCTGTCTGGCAGCAACTGTCCAAGGTGCTCTGGCTGCTAATATCGATGAGAGCAAAATTAAAGACACCGTTGATGACCTGATCCAGCCGCTGATGCAGAAGAATAATATTCCCGGTATGTCGGTCGCAGTGACCGTCAACGGTAAAAACTACATTTATAACTATGGGTTAGCGGCAAAACAGCCTCAGCAGCCGGTTACGGAAAATACGTTATTTGAAGTGGGTTCGCTGAGTAAAACGTTTGCTGCCACCTTGGCGTCCTATGCGCAGGTGAGCGGTAAGCTGTCTTTGGATCAAAGCGTTAGCCATTACGTTCCAGAGTTGCGTGGCAGCAGCTTTGACCACGTTAGCGTACTCAATGTGGGCACGCATACCTCAGGCCTACAGCTATTTATGCCGGAAGATATTAAAAATACCACACAGCTGATGGCTTATCTAAAAGCATGGAAACCTGCCGATGCGGCTGGAACCCATCGCGTTTATTCCAATATCGGTACTGGTTTGCTAGGGATGATTGCGGCGAAAAGTCTGGGTGTGAGCTATGAAGATGCGATTGAGAAAACCCTCCTTCCTCAGTTAGGCATGCATCACAGCTACTTGAAGGTTCCGGCTGACCAGATGGAAAACTATGCGTGGGGCTACAACAAGAAAGATGAGCCAGTGCACGTGAATATGGAGATTTTGGGTAACGAAGCTTATGGTATCAAAACCACCTCCAGCGACTTGTTACGCTACGTGCAAGCCAATATGGGGCAGTTAAAGCTTGATGCTAATGCCAAGATGCAACAGGCTCTGACAGCCACCCACACCGGCTATTTCAAATCGGGTGAGATTACTCAGGATCTGATGTGGGAGCAGCTGCCATATCCGGTTTCTCTGCCGAATTTGCTCACCGGTAACGATATGGCGATGACGAAAAGCGTGGCTACGCCGATTGTTCCGCCGTTACCGCCACAGGAAAATGTGTGGATTAATAAGACCGGATCAACTAACGGCTTCGGTGCCTATATTGCGTTTGTTCCTGCTAAGAAGATGGGGATCGTGATGCTGGCTAACAAAAACTACTCAATCGATCAGCGAGTGACGGTGGCGTATAAAATCCTGAGCTCATTGGAAGGGAATAAGTAG	MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	101.04	gnl|BL_ORD_ID|1572|hsp_num:0	1663	True	possible complete gene, reference contained within open reading frame
DAAGAT010000087.1_1 # 66 # 1286 # 1 # ID=87_1;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.499	DAAGAT010000087.1_1	66	1286	+	Strict	700	775.007	EreA2	92.4	3002826	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGACATGGAGAACGACCAGAACACTTTTACAGCCTCAAAAGCTGGACTTCAATGAGTTTGAGATTCTTACTTCCGTAATTGAGGGCGCCCGAATTGTCGGCATTGGCGAGGGCGCTCATTTTGTCGCGGAGTTTTCACTGGCTAGAGCTAGTCTTATCCGCTATTTGGTCGAAAGGCATGAGTTTAATGCGATTGGTTTGGAATGTGGGGCGATTCAGGCATCCCGGTTATCTGAATGGCTCAACTCAACAGCCGGTGCTCATGAACTTGAGCGATTTTCGGATACCCTGACCTTTTCTGTGTATGGCTCAGTGCTGATCTGGCTGAAATCATATCTCCGCGAATCAGGAAGAAAACTGCAGTTAGTCGGAATCGACTTACCCAACACCCTGAACCCAAGGGACGACCTAGCGCAATTGGCCGAAATTATCCAGCTCATCGATCACCTCATGAAACCGCACGTTGATATGTTGACTCACTTGTTGGCGTCCATTGATGGCCAGTCGGCGGTTATTTCATCGGCAAAATGGGGGGAGCTAGAAACGGCTCGGCAGGAGAAAGCTATCTCAGGGGTAACCAGATTGAAGCTCCGCTTGGCGTCGCTTGCCCCCGTCCTGAAAAAACACGTCAACAGCGATTTGTTCCGAAAAGCCTCTGATCGAATAGAGTCGATAGAGTATACGTTGGAAACCTTGCGTATAATGAAAACTTTCTTCGATGGTACCTCTCTTGAGGGAGATACTTCCGTACGTGACTCGTATATGGCGGGCGTAGTAGATGGAACGGTTCGAGCGAATCCGGATGTGAAGATAATTCTGCTGGCGCACAACAATCATTTACAAAAAACTCCAGTCTCCTTTTCAGGCGAGCTTACGGCTGTTCCCATGGGGCAGCACCTCGCAGAGAGGGTGAATTACCGTGCGATTGCATTCACCCATCTTGGACCCACCGTGCCGGAAATGCATTTCCCATCGCCAAAAAGTCCTCTTGGATTCTCTGTTGTGACCACGCCTGCCGATGCAATCCGTGAGGATAGTATGGAACAGTATGTCATCGACGCCTGTGGTACGGAGAATTCATGTCTGACATTGACAGATGCCCCCATGGAAGCAAAGCGAATGCGGTCTCAAAGCGCCTCTGTAGAAACGAAATTGAGCGAGGCATTTGATGCCATCGTCTGTGTTACAAGCGCCGGCAAGGACAGCCTGGTTGCCCTATAG	MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERHEFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGELETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFDGTSLEGDTSVRDSYMAGVVDGTVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHLAERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENSCLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL	MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERHDFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGELETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHLAEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKEDSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL	99.51	gnl|BL_ORD_ID|1431|hsp_num:0	1518		
DAAGAT010000088.1_1 # 3 # 803 # 1 # ID=88_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.528	DAAGAT010000088.1_1	3	803	+	Strict	450	533.487	ANT(3'')-IIa	99.62	3004089	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	TTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACGTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAGTTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATTGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAGAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAA	LNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	MVTAQWRFSWLLVMTCFFGVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	82.35	gnl|BL_ORD_ID|2455|hsp_num:0	2752		
DAAGAT010000089.1_1 # 3 # 803 # 1 # ID=89_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.527	DAAGAT010000089.1_1	3	803	+	Strict	450	533.487	ANT(3'')-IIa	99.62	3004089	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	TTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAGAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAA	LNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	MVTAQWRFSWLLVMTCFFGVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	82.35	gnl|BL_ORD_ID|2455|hsp_num:0	2752		
DAAGAT010000002.1_130 # 147705 # 149471 # -1 # ID=2_130;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.547	DAAGAT010000002.1_130 	147705	149471	-	Strict	500	587.8	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	52.9	3004446	protein variant model	D350N, S357N	n/a	cephalosporin; cephamycin; penam	antibiotic target alteration	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	ATGAAAGCAGCGGCAAAAACGCAAAAATCGAAGCGCCAGGAAGAACAGACCAACTTCATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTTTACTGGCGCTGGTTTTTTTACTTGGACGCGCGGCGTGGCTACAGATTATCGCCCCGGATATGCTGGTGCGTCAGGGCGATATGCGTTCGCTGCGTGTTCAGGAAGTCTCCACCTCACGCGGTATGATTACCGATCGTTCCGGGCGTCCACTGGCGGTCAGCGTACCGGTTAAGGCGATCTGGGCCGACCCTAAAGAAGTTCATGACGCCGGCGGCATCAGCGTCGGCGATCGCTGGAAAGCGCTTTCTACTGCGCTCAATATTCCGCTCGATCAGCTCTCCGCCCGTATCAACGCCAACCCGAAAGGGCGTTTTATTTATCTGGCGCGCCAGGTAAATCCTGACATGGCGGACTACATCAAAAAACTCAAACTGCCGGGGATTCATTTGCGTGAAGAATCACGCCGCTACTACCCGTCAGGAGAAGTAACCGCTCACCTCATCGGTTTTACCAACGTCGATAGTCAGGGGATTGAAGGCGTTGAAAAGAGCTTTGATAAGTGGCTTACCGGTCAGCCTGGCGAGCGAATCGTGCGTAAAGACCGCTATGGCCGCGTGATTGAGGATATCTCCTCCACTGACAGTCAGGCAGCGCACAACCTGGCGTTAAGCATTGATGAACGCTTACAGGCGCTGGTTTACCGCGAACTGAACAACGCGGTGGCGTTTAACAAGGCGGAATCCGGTAGCGCGGTGCTGGTCGATGTCAATACCGGTGAAGTACTGGCGATGGCGAATAGCCCTTCCTATAACCCCAACAACCTTGCCGGTACGCCGAAAGACGCGATGCGTAACCGTACCATCACCGACGTGTTTGAACCGGGTTCTACGGTTAAGCCGATGGTGGTGATGACTGCGCTTCAGCGCGGTATCGTCAACGAAAATACGGTGTTGAATACCGTTCCATACCGAATTAACGGCCACGAAATTAAAGACGTGGCGCGCTACAGCGAATTAACCCTGACCGGGGTTCTACAGAAGTCGAGTAACGTCGGTGTATCCAAACTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTAGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCCGACATAGAGAGGGCCACCTTCTCTTTCGGCTACGGGCTAATGGTAACGCCGTTACAATTAGCGCGAGTCTATGCAACGATCGGCAGCTATGGCATTTATCGCCCGCTGTCGATTACCAAAGTTGATCCGCCTGTACCCGGCGAACGCATCTTCCCTGAATCCACCGTACGCACCGTGGTGCATATGATGGAAAGCGTAGCGCTGCCGGGCGGCGGCGGCGTGAAGGCAGCGATTAAAGGCTACCGTATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGACGGTCGCTACATCAACAAATACATTGCTTACACCGCAGGCGTCGCGCCTGCGAGTCAGCCGCGCTTCGCGCTGGTGGTTGTCATCAACGATCCGCAGGCGGGTAAATACTACGGCGGCGCCGTTTCCGCGCCGGTATTTGGTGCCATCATGGGCGGCGTTCTGCGCACCATGAACATCGAACCGGACGCGCTGGCAACGGGCGAAAAAAATGAATTCGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	MKAAAKTQKSKRQEEQTNFISWRFALLCGCILLALVFLLGRAAWLQIIAPDMLVRQGDMRSLRVQEVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALSTALNIPLDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLAGTPKDAMRNRTITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERIFPESTVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKNEFVINQGEGTGGRS	MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN	96.39	gnl|BL_ORD_ID|2569|hsp_num:0	2886		
DAAGAT010000006.1_26 # 24736 # 26127 # 1 # ID=6_26;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.547	DAAGAT010000006.1_26 	24736	26127	+	Strict	850	876.7	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	95.68	3003890	protein variant model	E350Q	n/a	fosfomycin	antibiotic target alteration	UhpT	ATGCTGGCCTTCTTAAACCAGGTGCGTAAGCCGACCCTGGATCTGCCGCTCGATGTGCGGCGTAAAATGTGGTTCAAGCCGTTCATGCAGTCCTATCTGGTGGTTTTTATCGGCTACCTGACCATGTACCTGATCCGCAAAAACTTTAACATCGCGCAGAACGACATGATCTCTACCTACGGGTTGAGCATGACCGAGCTGGGGATGATTGGCCTGGGCTTCTCGATCACCTATGGCGTGGGGAAAACGCTGGTTTCCTACTACGCTGACGGTAAAAATACCAAGCAGTTTCTACCGTTTATGTTGATCCTCTCCGCTATCTGTATGCTCGGCTTCAGCGCCAGCATGGGCGCGGGGTCAACCAGTCTGTTTCTGATGATCGCTTTCTATGCCCTGAGCGGTTTCTTCCAGAGTACCGGCGGATCGTGCAGCTACTCGACCATCACCAAATGGACTCCGCGTCGTAAACGCGGCACCTTTCTCGGCTTCTGGAATATCTCCCACAACCTCGGCGGCGCGGGCGCGGCAGGCGTGGCGCTGTTCGGCGCCAACTACCTGTTCGACGGTCACGTCATCGGCATGTTTATCTTCCCGTCGATTATCGCGCTGATTGTTGGCTTTATCGGTCTGCGTTTTGGCAGCGACTCCCCGGAGTCTTACGGTCTGGGTAAAGCTGAAGAACTGTTCGGCGAAGAGATCAGCGAAGAGGATAAAGAGACTGAAGAAAACGAAATGACCAAGTGGCAGATCTTTGTTGAATATGTGTTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAATATCTTCCTGTATGTGGTACGTATTGGTATCGACCAGTGGTCAACCGTCTACGCCTTCCAGGAACTGAAACTTTCTAAAGAGGTGGCGATTCAGGGCTTTACCTTGTTTGAAGTGGGCGCGCTGGTCGGCACGTTGCTGTGGGGCTGGCTCTCTGACCTGGCGAACGGTCGTCGTGCGCTGGTAGCCTGTGTGGCGCTGGCGTTAATCATCGCCACCCTCGGCGTCTACCAGCACGCCAGCAACCAGTATGTCTATCTGGCCTCGCTGTTCGCGCTCGGTTTCCTGGTGTTTGGGCCGCAGCTATTAATTGGCGTGGCGGCAGTCGGTTTCGTACCGAAAAAAGCCATCGGCGCTGCGGACGGTATCAAAGGAACCTTCGCTTATCTTATCGGCGATAGCTTTGCCAAGCTGGGTCTGGGCATGATTGCCGACGGCACCCCCGTTTTTGGTCTGACCGGCTGGGCGGGCACCTTCGCCGCGCTGGACGCCGCCGCGATCGGCTGTATCTGCCTGATGGCGATGGTCGCCGTGATGGAAGAGCGCAAAATCCGCCGTGAGAAAAAAATTCAGCAAGTTAATATCGCTTAA	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTELGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRFGSDSPESYGLGKAEELFGEEISEEDKETEENEMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACVALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAIGCICLMAMVAVMEERKIRREKKIQQVNIA	MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA	100.00	gnl|BL_ORD_ID|2195|hsp_num:0	2373		
DAAGAT010000012.1_112 # 117220 # 118578 # 1 # ID=12_112;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.547	DAAGAT010000012.1_112 	117220	118578	+	Strict	850	895.575	Escherichia coli GlpT with mutation conferring resistance to fosfomycin	96.9	3003889	protein variant model	E448K	n/a	fosfomycin	antibiotic target alteration	GlpT	ATGTTGAGTATTTTTAAACCAGCGCCGCATAAAGCGCGCTTGCCAGCGGCGGAGATTGATCCGACCTATCGCCGATTACGCTGGCAGATTTTCCTGGGGATATTCTTTGGCTATGCCGCGTATTATCTGGTGCGCAAGAACTTTGCCCTCGCGATGCCCTACCTGGTAGAACAGGGTTTTTCACGCGGCGATCTGGGCTTTGCGTTGTCCGGGATTTCCATCGCTTATGGTTTTTCGAAATTTATAATGGGTTCGGTGTCCGATCGCTCGAATCCGCGCGTTTTTCTGCCGGCAGGGTTGATTCTGGCCGCAGCAGTCATGTTGTTTATGGGCTTTGTACCGTGGGCGACATCCAGCATCGCCGTGATGTTTGTGCTGTTGTTCCTTTGCGGCTGGTTCCAGGGGATGGGGTGGCCGCCGTGCGGACGTACAATGGTTCACTGGTGGTCGCAGAAAGAGCGCGGCGGCATTGTGTCGGTCTGGAACTGTGCGCATAACGTCGGCGGCGGGATCCCGCCACTGCTGTTCCTGCTGGGGATGGCGTGGTTTAACGACTGGAAAGCGGCGCTCTATATGCCAGCCTTTGGCGCGATTGTGGTGGCGCTGTTCGCTTTCGCAATGATGCGCGATACGCCGCAATCCTGCGGTCTGCCGCCTATCGAAGAGTATAAAAACGACTATCCGGACGACTACAACGAAAAAGCGGAAGAAGAGCTGACTGCGAAGCAGATCTTCATGCAGTACGTACTGCCAAACAAACTGTTGTGGTACATCGCTATCGCCAACGTGTTTGTTTATCTGCTGCGCTACGGCATCCTCGACTGGTCGCCGACCTACCTGAAAGAAGTGAAGCATTTCGCACTGGATAAATCCTCCTGGGCCTACTTCCTGTATGAATACGCGGGTATTCCGGGCACGCTGCTGTGTGGCTGGATGTCGGATAAAGTCTTCCGCGGCAACCGTGGCGCGACCGGCGTGTTCTTTATGACCCTGGTGACTATCGCGACCATCGTTTACTGGATGAACCCGGCAGGAAACCCGAACGTTGATATGGCTTGTATGATTATCATCGGCTTCCTGATCTACGGCCCGGTAATGTTGATCGGTCTGCACGCGCTGGAACTGGCGCCGAAAAAAGCGGCGGGTACGGCGGCGGGCTTTACCGGTCTGTTTGGTTACCTGGGCGGTTCTGTCGCTGCAAGCGCCATTGTGGGTTATACCGTTGACTTCTTCGGTTGGGATGGCGGCTTTATGGTGATGATTGGCGGCAGCATTCTGGCGGTAATCCTGCTGGTGGTCGTGATGATTGGTGAAAAACGCCATCATGATGAGCTGCAGTTAAAACGCAACGGAGGCTAA	MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGMAWFNDWKAALYMPAFGAIVVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEEELTAKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPNVDMACMIIIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGSILAVILLVVVMIGEKRHHDELQLKRNGG	MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGFSRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSIAVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGMAWFNDWHAALYMPAFCAILVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEQELTAKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEYAGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPTVDMICMIVIGFLIYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVMIGGSILAVILLIVVMIGEKRRHEQLLQERNGG	100.00	gnl|BL_ORD_ID|2196|hsp_num:0	2372		
DAAGAT010000073.1_1 # 1 # 471 # 1 # ID=73_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.527	DAAGAT010000073.1_1 	1	471	+	Strict	700	315.464	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin	99.36	3003369	protein variant model	R234F	n/a	elfamycin antibiotic	antibiotic target alteration	elfamycin resistant EF-Tu	CTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGCGAAAATCATCGAACTGGCTGGCTTCCTGGATTCTTACATCCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAACGCGGTATCATCAAAGTGGGCGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTCAGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCCGGTGAGAACGTAGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCACCATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGATGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTAC	LKALEGDAEWEAKIIELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFY	MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG	38.39	gnl|BL_ORD_ID|2025|hsp_num:0	2158	True	loose hit with at least 95 percent identity pushed strict
DAAGAT010000001.1_288 # 284132 # 284566 # -1 # ID=1_288;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	DAAGAT010000001.1_288	284132	284566	-	Strict	210	273.478	Escherichia coli marR mutant conferring antibiotic resistance	92.36	3003378	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAAAAGCACCAGTGATCTGTTCAATGAAATCATTCCGCTGGGTCGCTTGATCTACATGGTAAATCAAAAAAAAGATCGCCTGTTAAATAACTATTTATCCCCGCTGGATATCACCGCAACACAGTTTAAAGTGCTGTGCTCGATACGCTGCGCGGGATGTATTACCCCGGTTGAACTTAAAAAAGTGCTGTCTGTCGATCTCGGCGCATTGACGCGGATGCTCGACCGCCTGCTGTGCAAAGGCTGGATCGAAAGACTGCCAAATCCTAATGACAAACGCGGCGTACTGGTGAAGCTAACGCCGGACGGCGCGGCAATTTGTGAGCAATGTCATCAACGACCAGGGCAAGACCTGCATCAGGAATTAACAAAAAACTTAACGGCGGACGAAGTGGCAACGCTTGAGTATTTGCTCAAGAAAATTCTGCCGTAG	LKSTSDLFNEIIPLGRLIYMVNQKKDRLLNNYLSPLDITATQFKVLCSIRCAGCITPVELKKVLSVDLGALTRMLDRLLCKGWIERLPNPNDKRGVLVKLTPDGAAICEQCHQRPGQDLHQELTKNLTADEVATLEYLLKKILP	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	100.00	gnl|BL_ORD_ID|2043|hsp_num:0	431		
DAAGAT010000014.1_78 # 81481 # 82134 # -1 # ID=14_78;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.462	DAAGAT010000014.1_78	81481	82134	-	Strict	375	391.734	Escherichia coli acrR with mutation conferring multidrug antibiotic resistance	86.92	3003807	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; penam; tetracycline antibiotic; acridine dye; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; triclosan; antibacterial free fatty acids	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCACGAAAAACCAAACAACAAGCGCTGGAGACACGACAACACATCCTGGATGTGGCCCTGCGTTTGTTCTCGCAGCAAGGCGTATCAGCAACCTCGCTGGCGGAGATTGCGAACGCTGCTGGCGTGACGCGCGGCGCAATCTATTGGCATTTCAAAAATAAGTCGGATTTATTCAGTGAGATCTGGGAGCTATCAGAATCCAATATTGGTGAGCTTGAGATTGAGTATCAGGCAAAATTCCCCGACGATCCACTATCTGTATTAAGAGAAATTTTAGTTCATATTCTTGAAGCTACTGTAACAGAAGAACGACGCCGCTTATTGATGGAGATTATATTCCATAAATGTGAGTTTGTCGGAGAAATGGTTGTGGTTCAACAGGCGCAACGTAGCCTTTGTCTGGAAAGTTACGATCGGATTGAACAAACGTTAAAACATTGTATTAATGCTAAAATGCTGCCTGAAAATCTGCTGACCCGTCGTGCGGCGATACTGATGCGCAGCTTTATTTCAGGGCTCATGGAAAACTGGTTATTTGCTACGCAATCGTTTGATTTAAAAAAAGAAGCTCGCGCCTACGTCACGATCCTGCTGGAGATGTATCAATTGTGTCCGACGCTGCGCGCGTCGACGGTCAACGGCTCCCCCTGA	MARKTKQQALETRQHILDVALRLFSQQGVSATSLAEIANAAGVTRGAIYWHFKNKSDLFSEIWELSESNIGELEIEYQAKFPDDPLSVLREILVHILEATVTEERRRLLMEIIFHKCEFVGEMVVVQQAQRSLCLESYDRIEQTLKHCINAKMLPENLLTRRAAILMRSFISGLMENWLFATQSFDLKKEARAYVTILLEMYQLCPTLRASTVNGSP	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	100.93	gnl|BL_ORD_ID|2153|hsp_num:0	2306		
DAAGAT010000017.1_12 # 13614 # 14072 # -1 # ID=17_12;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.547	DAAGAT010000017.1_12	13614	14072	-	Strict	300	300.056	Escherichia coli soxR with mutation conferring antibiotic resistance	96.05	3003381	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; lincosamide antibiotic; carbapenem; fosfomycin; cephalosporin; glycylcycline; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; pleuromutilin antibiotic; triclosan; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAAAAAAAATCTCCCCGTTTAAAAGCCTTACTGACGCCGGGGGAAGTTGCGAAACGTAGCGGTGTTGCTGTGTCCGCCCTGCACTTCTATGAAAGCAAAGGGCTAATTACCAGTATCCGTAATAGCGGTAACCAACGGCGATACAAGCGTGACGTGTTGCGTTATGTCGCGATTATCAAGATCGCCCAGCGTATCGGCATCCCGCTGGCAACTATCGGCGACGCGTTTGGTATCTTGCCGGAAGGACATACGTTAAGCGCGAAAGAGTGGAAGCAGCTCTCCTCGCAGTGGCGCGAAGAGTTAGACCGACGTATTCATACGCTGGTGGCGTTGCGCGATGAGCTGGACGGTTGTATCGGCTGCGGCTGTTTATCGCGTAGCGACTGTCCGCTGCGAAATCCAGGCGACAGGCTTGGCGAACACGGGACGGGTGCCCGGCTGCTTGAAGATGATTAA	MEKKSPRLKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIGDAFGILPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEHGTGARLLEDD	MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN	98.70	gnl|BL_ORD_ID|2028|hsp_num:0	1005		
DAAGAT010000017.1_13 # 14159 # 14482 # 1 # ID=17_13;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.509	DAAGAT010000017.1_13	14159	14482	+	Strict	200	212.231	Escherichia coli soxS with mutation conferring antibiotic resistance	95.33	3003511	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; lincosamide antibiotic; carbapenem; fosfomycin; cephalosporin; glycylcycline; cephamycin; bicyclomycin; penam; nucleoside antibiotic; tetracycline antibiotic; peptide antibiotic; acridine dye; oxazolidinone antibiotic; aminocoumarin antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; isoniazid; pleuromutilin antibiotic; triclosan; penem; benzalkonium chloride; rhodamine; antibacterial free fatty acids; nitroimidazole antibiotic	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGTCGCATCAGCAGATAATTCAGACCCTTATCGAATGGATTGATGAACATATCGACCAACCGCTAAACATTGATGTGGTGGCAAAAAAATCGGGCTACTCCAAGTGGTATTTACAGCGGATGTTTCGTACGGTAACGCATCAAACATTAGGCGAGTATATTCGCCAGCGCCGTCTCCTGTTGGCGGCTGTTGAGCTACGAACGACCGAGCGCCCGATTTTTGATATCGCGATGGACCTGGGCTATGTATCGCAGCAAACCTTCTCGCGTGTATTCCGCCGCGAGTTCGATCGCACTCCCAGCGATTACCGTCACCGCCTGTAG	MSHQQIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGEYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHRL	MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL	100.00	gnl|BL_ORD_ID|2031|hsp_num:0	2066		
